{"AllianceGenome": "1366", "HGNC": "1366", "MIM": "604134", "_id": "11093", "_version": 2, "accession": {"genomic": ["AL158826.23", "AL593848.15", "AY532929.1", "AY532930.1", "AY532931.1", "AY532932.1", "CH471090.1", "CP068269.2", "DQ422807.1", "GU592206.1", "MF630952.1", "NC_000009.12", "NC_060933.1", "NG_011934.2", "NW_009646201.1"], "protein": ["AAL11094.1", "AAL11095.1", "AAL17652.1", "AAQ88485.1", "AAS54901.1", "AAS54902.1", "AAS54903.1", "AAS54904.1", "ABD72606.1", "ADD92168.1", "ASW23237.1", "BAB69487.2", "BAF85128.1", "BAG54119.1", "CAB66157.1", "CAB66743.1", "CAC83682.1", "CAD12729.1", "CAD12730.1", "CAI12850.1", "CAI12851.1", "CAI12852.1", "EAW88083.1", "EAW88084.1", "EAW88085.1", "EAW88086.1", "EAW88087.1", "EAW88088.1", "NP_620594.1", "NP_620595.1", "NP_620596.2", "Q76LX8.1", "XP_011516478.1", "XP_011516480.1", "XP_011516481.1", "XP_016869721.1", "XP_016869722.1", "XP_016869723.1", "XP_016869724.1", "XP_047278655.1", "XP_047278656.1", "XP_054187537.1", "XP_054187538.1", "XP_054187539.1", "XP_054187540.1", "XP_054187541.1", "XP_054187542.1", "XP_054187543.1", "XP_054187544.1", "XP_054187545.1", "XP_054217833.1", "XP_054217834.1", "XP_054217835.1", "XP_054217836.1", "XP_054217837.1", "XP_054217838.1", "XP_054217839.1"], "rna": ["AB069698.2", "AF414400.1", "AF414401.1", "AJ011374.1", "AJ305314.1", "AJ420810.1", "AJ420811.1", "AK124983.1", "AK292439.1", "AL136809.1", "AV655072.1", "AW197188.1", "AY055376.1", "AY358118.1", "BC034404.1", "BC039251.1", "BC103828.1", "BC103829.1", "BC103830.1", "DB069518.1", "NM_139025.5", "NM_139026.6", "NM_139027.6", "NM_139028.2", "NR_024514.3", "XM_011518176.4", "XM_011518178.3", "XM_011518179.1", "XM_017014232.2", "XM_017014233.2", "XM_017014234.2", "XM_017014235.2", "XM_047422699.1", "XM_047422700.1", "XM_054331562.1", "XM_054331563.1", "XM_054331564.1", "XM_054331565.1", "XM_054331566.1", "XM_054331567.1", "XM_054331568.1", "XM_054331569.1", "XM_054331570.1", "XM_054361858.1", "XM_054361859.1", "XM_054361860.1", "XM_054361861.1", "XM_054361862.1", "XM_054361863.1", "XM_054361864.1"], "translation": [{"protein": "NP_620595.1", "rna": "NM_139026.6"}, {"protein": "XP_054217838.1", "rna": "XM_054361863.1"}, {"protein": "NP_620596.2", "rna": "NM_139027.6"}, {"protein": "CAB66157.1", "rna": "AJ011374.1"}, {"protein": "XP_054187537.1", "rna": "XM_054331562.1"}, {"protein": "XP_054187542.1", "rna": "XM_054331567.1"}, {"protein": "XP_054187545.1", "rna": "XM_054331570.1"}, {"protein": "XP_054187543.1", "rna": "XM_054331568.1"}, {"protein": "XP_054187538.1", "rna": "XM_054331563.1"}, {"protein": "XP_011516481.1", "rna": "XM_011518179.1"}, {"protein": "XP_016869724.1", "rna": "XM_017014235.2"}, {"protein": "XP_047278656.1", "rna": "XM_047422700.1"}, {"protein": "XP_054187541.1", "rna": "XM_054331566.1"}, {"protein": "CAD12730.1", "rna": "AJ420811.1"}, {"protein": "BAB69487.2", "rna": "AB069698.2"}, {"protein": "AAL11095.1", "rna": "AF414401.1"}, {"protein": "BAG54119.1", "rna": "AK124983.1"}, {"protein": "XP_016869723.1", "rna": "XM_017014234.2"}, {"protein": "XP_054217833.1", "rna": "XM_054361858.1"}, {"protein": "AAL11094.1", "rna": "AF414400.1"}, {"protein": "XP_016869721.1", "rna": "XM_017014232.2"}, {"protein": "CAB66743.1", "rna": "AL136809.1"}, {"protein": "XP_054217834.1", "rna": "XM_054361859.1"}, {"protein": "XP_054217837.1", "rna": "XM_054361862.1"}, {"protein": "XP_054187539.1", "rna": "XM_054331564.1"}, {"protein": "XP_054217836.1", "rna": "XM_054361861.1"}, {"protein": "XP_011516480.1", "rna": "XM_011518178.3"}, {"protein": "AAQ88485.1", "rna": "AY358118.1"}, {"protein": "XP_054187540.1", "rna": "XM_054331565.1"}, {"protein": "CAD12729.1", "rna": "AJ420810.1"}, {"protein": "XP_054217839.1", "rna": "XM_054361864.1"}, {"protein": "XP_011516478.1", "rna": "XM_011518176.4"}, {"protein": "BAF85128.1", "rna": "AK292439.1"}, {"protein": "NP_620594.1", "rna": "NM_139025.5"}, {"protein": "XP_016869722.1", "rna": "XM_017014233.2"}, {"protein": "XP_054187544.1", "rna": "XM_054331569.1"}, {"protein": "XP_047278655.1", "rna": "XM_047422699.1"}, {"protein": "AAL17652.1", "rna": "AY055376.1"}, {"protein": "CAC83682.1", "rna": "AJ305314.1"}, {"protein": "XP_054217835.1", "rna": "XM_054361860.1"}]}, "alias": ["ADAM-TS13", "ADAMTS-13", "C9orf8", "VWFCP", "vWF-CP"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2020-03-25T16:00:00.000Z", "disease_label": "congenital thrombotic thrombocytopenic purpura", "gcep": "Hemostasis/Thrombosis Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0010122", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6442c328-21be-482d-9ea9-ce694c1a5dd9-2020-03-25T160000.000Z", "sop": "SOP6"}}, "ec": "3.4.24.87", "ensembl": [{"gene": "ENSG00000160323", "protein": ["ENSP00000347927", "ENSP00000348997", "ENSP00000360978", "ENSP00000360979", "ENSP00000360984", "ENSP00000360997", "ENSP00000435274", "ENSP00000435305"], "transcript": ["ENST00000355699", "ENST00000356589", "ENST00000371910", "ENST00000371911", "ENST00000371916", "ENST00000371929", "ENST00000474918", "ENST00000485925", "ENST00000495234"], "translation": [{"protein": "ENSP00000360997", "rna": "ENST00000371929"}, {"protein": "ENSP00000360984", "rna": "ENST00000371916"}, {"protein": "ENSP00000360979", "rna": "ENST00000371911"}, {"protein": "ENSP00000435274", "rna": "ENST00000495234"}, {"protein": "ENSP00000348997", "rna": "ENST00000356589"}, {"protein": "ENSP00000435305", "rna": "ENST00000474918"}, {"protein": "ENSP00000347927", "rna": "ENST00000355699"}, {"protein": "ENSP00000360978", "rna": "ENST00000371910"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000281244", "protein": ["ENSP00000485845", "ENSP00000485989", "ENSP00000486060", "ENSP00000486201", "ENSP00000486371", "ENSP00000486734", "ENSP00000487185", "ENSP00000487509"], "transcript": ["ENST00000626079", "ENST00000626597", "ENST00000626661", "ENST00000626744", "ENST00000628339", "ENST00000629604", "ENST00000630344", "ENST00000630465", "ENST00000630700"], "translation": [{"protein": "ENSP00000486201", "rna": "ENST00000626597"}, {"protein": "ENSP00000487185", "rna": "ENST00000630344"}, {"protein": "ENSP00000486060", "rna": "ENST00000630700"}, {"protein": "ENSP00000485845", "rna": "ENST00000626079"}, {"protein": "ENSP00000486734", "rna": "ENST00000626744"}, {"protein": "ENSP00000485989", "rna": "ENST00000630465"}, {"protein": "ENSP00000486371", "rna": "ENST00000626661"}, {"protein": "ENSP00000487509", "rna": "ENST00000629604"}], "type_of_gene": "protein_coding"}], "entrezgene": "11093", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 44.8978190182, "exp_mis": 567.894759525, "exp_syn": 253.787656774, "lof_z": 3.08942768908419, "mis_z": 1.9887626996639, "mu_lof": 3.37194115609e-06, "mu_mis": 5.75597064263e-05, "mu_syn": 2.60953434103e-05, "n_lof": 24.0, "n_mis": 471.0, "n_syn": 224.0, "p_li": 7.88296728194754e-11, "p_null": 0.00152269193311512, "p_rec": 0.998477307988055, "syn_z": 1.15918068443859}, "bp": 4284, "cds_end": 136324302, "cds_start": 136287563, "n_exons": 29, "nonpsych": {"exp_lof": 40.1088464955, "exp_mis": 513.471561059, "exp_syn": 229.174321242, "lof_z": 3.11830845308583, "mis_z": 1.81346721318569, "mu_lof": 3.37194115609e-06, "mu_mis": 5.75597064263e-05, "mu_syn": 2.60953434103e-05, "n_lof": 20.0, "n_mis": 432.0, "n_syn": 202.0, "p_li": 1.10354763249969e-08, "p_null": 0.000919657195182007, "p_rec": 0.999080331769342, "syn_z": 1.13015740501222}, "nontcga": {"exp_lof": 41.2545276202, "exp_mis": 522.41174943, "exp_syn": 233.433200957, "lof_z": 3.41793483708118, "mis_z": 1.97073520074457, "mu_lof": 3.37194115609e-06, "mu_mis": 5.75597064263e-05, "mu_syn": 2.60953434103e-05, "n_lof": 19.0, "n_mis": 432.0, "n_syn": 212.0, "p_li": 8.01950029927773e-08, "p_null": 0.000216009352451337, "p_rec": 0.999783910452546, "syn_z": 0.888235250174426}, "transcript": "ENST00000371929.3"}, "exons": [{"cdsend": 285274, "cdsstart": 248537, "chr": "9_KN196479v1_fix", "position": [[248460, 248642], [249194, 249261], [250414, 250572], [251622, 251706], [252031, 252156], [252292, 252439], [254727, 254865], [256032, 256195], [258681, 258786], [259471, 259623], [259734, 259798], [262922, 263049], [263842, 263991], [264339, 264460], [265459, 265540], [266437, 266619], [268492, 268628], [268707, 268837], [269469, 269655], [270956, 271146], [271792, 271913], [274692, 274822], [275876, 276059], [280508, 280713], [281378, 281697], [282162, 282309], [282636, 282813], [284003, 284188], [285067, 285480]], "strand": 1, "transcript": "NM_139025", "txend": 285480, "txstart": 248460}, {"cdsend": 133459180, "cdsstart": 133422443, "chr": "9", "position": [[133422366, 133422548], [133423100, 133423167], [133424320, 133424478], [133425528, 133425612], [133425937, 133426062], [133426198, 133426345], [133428633, 133428771], [133429938, 133430101], [133432587, 133432692], [133433377, 133433529], [133433640, 133433704], [133436828, 133436955], [133437748, 133437897], [133438245, 133438366], [133439365, 133439446], [133440343, 133440525], [133442398, 133442534], [133442613, 133442743], [133443375, 133443561], [133444862, 133445052], [133445698, 133445819], [133448598, 133448728], [133449782, 133449965], [133454414, 133454619], [133455284, 133455603], [133456068, 133456215], [133456542, 133456719], [133457909, 133458094], [133458973, 133459386]], "strand": 1, "transcript": "NM_139025", "txend": 133459386, "txstart": 133422366}, {"cdsend": 285274, "cdsstart": 248537, "chr": "9_KN196479v1_fix", "position": [[248460, 248642], [249194, 249261], [250414, 250572], [251622, 251706], [252031, 252156], [252292, 252439], [254727, 254865], [256125, 256195], [258681, 258786], [259471, 259623], [259734, 259798], [262922, 263049], [263842, 263991], [264339, 264460], [265459, 265540], [266437, 266619], [268492, 268628], [268707, 268837], [269469, 269655], [270956, 271146], [271792, 271913], [274692, 274822], [275876, 276059], [280508, 280713], [281378, 281529], [282162, 282309], [282636, 282813], [284003, 284188], [285067, 285480]], "strand": 1, "transcript": "NM_139026", "txend": 285480, "txstart": 248460}, {"cdsend": 133459180, "cdsstart": 133422443, "chr": "9", "position": [[133422366, 133422548], [133423100, 133423167], [133424320, 133424478], [133425528, 133425612], [133425937, 133426062], [133426198, 133426345], [133428633, 133428771], [133430031, 133430101], [133432587, 133432692], [133433377, 133433529], [133433640, 133433704], [133436828, 133436955], [133437748, 133437897], [133438245, 133438366], [133439365, 133439446], [133440343, 133440525], [133442398, 133442534], [133442613, 133442743], [133443375, 133443561], [133444862, 133445052], [133445698, 133445819], [133448598, 133448728], [133449782, 133449965], [133454414, 133454619], [133455284, 133455435], [133456068, 133456215], [133456542, 133456719], [133457909, 133458094], [133458973, 133459386]], "strand": 1, "transcript": "NM_139026", "txend": 133459386, "txstart": 133422366}, {"cdsend": 133459180, "cdsstart": 133422443, "chr": "9", "position": [[133422366, 133422548], [133423100, 133423167], [133424320, 133424478], [133425528, 133425612], [133425937, 133426062], [133426198, 133426345], [133428633, 133428771], [133429938, 133430101], [133432587, 133432692], [133433377, 133433529], [133433640, 133433704], [133436828, 133436955], [133437748, 133437897], [133438245, 133438366], [133439365, 133439446], [133440343, 133440525], [133442398, 133442534], [133442613, 133442743], [133443375, 133443561], [133444862, 133445052], [133445698, 133445819], [133448598, 133448728], [133449782, 133449965], [133454414, 133454619], [133455284, 133455435], [133456068, 133456215], [133456542, 133456719], [133457909, 133458094], [133458973, 133459386]], "strand": 1, "transcript": "NM_139027", "txend": 133459386, "txstart": 133422366}, {"cdsend": 285274, "cdsstart": 248537, "chr": "9_KN196479v1_fix", "position": [[248460, 248642], [249194, 249261], [250414, 250572], [251622, 251706], [252031, 252156], [252292, 252439], [254727, 254865], [256032, 256195], [258681, 258786], [259471, 259623], [259734, 259798], [262922, 263049], [263842, 263991], [264339, 264460], [265459, 265540], [266437, 266619], [268492, 268628], [268707, 268837], [269469, 269655], [270956, 271146], [271792, 271913], [274692, 274822], [275876, 276059], [280508, 280713], [281378, 281529], [282162, 282309], [282636, 282813], [284003, 284188], [285067, 285480]], "strand": 1, "transcript": "NM_139027", "txend": 285480, "txstart": 248460}, {"cdsend": 133459386, "cdsstart": 133459386, "chr": "9", "position": [[133414336, 133414644], [133423100, 133423167], [133424320, 133424478], [133425528, 133425612], [133425937, 133426062], [133426198, 133426345], [133432587, 133432692], [133439365, 133439446], [133440343, 133440525], [133444862, 133445052], [133445698, 133445819], [133448598, 133448728], [133449782, 133449965], [133454414, 133454619], [133455284, 133455435], [133456068, 133456215], [133456542, 133456719], [133458973, 133459386]], "strand": 1, "transcript": "NR_024514", "txend": 133459386, "txstart": 133414336}, {"cdsend": 285480, "cdsstart": 285480, "chr": "9_KN196479v1_fix", "position": [[240430, 240738], [249194, 249261], [250414, 250572], [251622, 251706], [252031, 252156], [252292, 252439], [258681, 258786], [265459, 265540], [266437, 266619], [270956, 271146], [271792, 271913], [274692, 274822], [275876, 276059], [280508, 280713], [281378, 281529], [282162, 282309], [282636, 282813], [285067, 285480]], "strand": 1, "transcript": "NR_024514", "txend": 285480, "txstart": 240430}], "exons_hg19": [{"cdsend": 136324302, "cdsstart": 136287563, "chr": "9", "position": [[136287486, 136287668], [136288220, 136288287], [136289440, 136289598], [136290648, 136290732], [136291057, 136291182], [136291318, 136291465], [136293753, 136293891], [136295058, 136295221], [136297708, 136297813], [136298497, 136298649], [136298760, 136298824], [136301948, 136302075], [136302868, 136303017], [136303365, 136303486], [136304486, 136304567], [136305464, 136305646], [136307519, 136307655], [136307734, 136307864], [136308496, 136308682], [136309983, 136310173], [136310819, 136310940], [136313719, 136313849], [136314903, 136315086], [136319536, 136319741], [136320406, 136320725], [136321190, 136321337], [136321664, 136321841], [136323031, 136323216], [136324095, 136324508]], "strand": 1, "transcript": "NM_139025", "txend": 136324508, "txstart": 136287486}, {"cdsend": 136324302, "cdsstart": 136287563, "chr": "9", "position": [[136287486, 136287668], [136288220, 136288287], [136289440, 136289598], [136290648, 136290732], [136291057, 136291182], [136291318, 136291465], [136293753, 136293891], [136295151, 136295221], [136297708, 136297813], [136298497, 136298649], [136298760, 136298824], [136301948, 136302075], [136302868, 136303017], [136303365, 136303486], [136304486, 136304567], [136305464, 136305646], [136307519, 136307655], [136307734, 136307864], [136308496, 136308682], [136309983, 136310173], [136310819, 136310940], [136313719, 136313849], [136314903, 136315086], [136319536, 136319741], [136320406, 136320557], [136321190, 136321337], [136321664, 136321841], [136323031, 136323216], [136324095, 136324508]], "strand": 1, "transcript": "NM_139026", "txend": 136324508, "txstart": 136287486}, {"cdsend": 136324302, "cdsstart": 136287563, "chr": "9", "position": [[136287486, 136287668], [136288220, 136288287], [136289440, 136289598], [136290648, 136290732], [136291057, 136291182], [136291318, 136291465], [136293753, 136293891], [136295058, 136295221], [136297708, 136297813], [136298497, 136298649], [136298760, 136298824], [136301948, 136302075], [136302868, 136303017], [136303365, 136303486], [136304486, 136304567], [136305464, 136305646], [136307519, 136307655], [136307734, 136307864], [136308496, 136308682], [136309983, 136310173], [136310819, 136310940], [136313719, 136313849], [136314903, 136315086], [136319536, 136319741], [136320406, 136320557], [136321190, 136321337], [136321664, 136321841], [136323031, 136323216], [136324095, 136324508]], "strand": 1, "transcript": "NM_139027", "txend": 136324508, "txstart": 136287486}, {"cdsend": 136324508, "cdsstart": 136324508, "chr": "9", "position": [[136279456, 136279764], [136288220, 136288287], [136289440, 136289598], [136290648, 136290732], [136291057, 136291182], [136291318, 136291465], [136297708, 136297813], [136304486, 136304567], [136305464, 136305646], [136309983, 136310173], [136310819, 136310940], [136313719, 136313849], [136314903, 136315086], [136319536, 136319741], [136320406, 136320557], [136321190, 136321337], [136321664, 136321841], [136324095, 136324508]], "strand": 1, "transcript": "NR_024514", "txend": 136324508, "txstart": 136279456}], "generif": [{"pubmed": 11586344, "text": "incodes a zinc proteinase involved in thrombotic thrombocytopenic purpura"}, {"pubmed": 11586351, "text": "mutation of gene causes thrombotic thrombocytopenic purpura"}, {"pubmed": 11843286, "text": "VWF-CPis composed of a single polypeptide with a molecular mass of approx. 190 kD,and cDNA cloning indicated it is uniquely produced in the liver. Its gene is on chromosome 9q34."}, {"pubmed": 11920264, "text": "role of the vWF protease and vWF proteolysis in the pathogenesis of bone marrow transplant-associated thrombotic microangiopathy of the fulminant type"}, {"pubmed": 12038781, "text": "Complete defect in vWF-cleaving protease activity is associated with increased shear-induced platelet aggregation in thrombotic microangiopathy."}, {"pubmed": 12084165, "text": "An acquired deficiency of vWF-CP due to an autoantibody is associated with responsiveness to plasma exchange therapy in TTP. Patients whose TTP is not caused by autoimmunity to vWF-CP may not respond to PE."}, {"pubmed": 12091044, "text": "Deficiency of vWF-cp activity in patients with colon cancer was shown to be associated with the progression of the disease and metastasis."}, {"pubmed": 12091372, "text": "A severely deficient activity is specific for thrombotic thrombocytopenic purpura."}, {"pubmed": 12130486, "text": "ADAMTS13 is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome; its activity level cannot be used to distingush between TTP and HUS."}, {"pubmed": 12172456, "text": "REVIEW: role of ADAMTS13 mutations and deficiencies in thrombotic microangiopathies"}, {"pubmed": 12181489, "text": "mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity"}, {"pubmed": 12195022, "text": "role of variation in modulating risk of thrombosis in cardiovascular disorders"}, {"pubmed": 12223999, "text": "a sensitive blood indicator for diagnosing thrombocytopenic thrombotic purpura"}, {"pubmed": 12393397, "text": "ADAMTS-13 rapidly cleaves newly secreted ultralarge VWF multimers on the vascular endothelial surface under flowing conditions"}, {"pubmed": 12393399, "text": "Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)."}, {"pubmed": 12393505, "text": "Mutation analysis of the ADAMTS13 gene in the childhood TTP patients deficient in VWF-CP by direct sequencing of all 29 exons identified 8 different mutations."}, {"pubmed": 12395148, "text": "vWF proteolysis by ADAMTS13 is critical in regulating vWF-platelet interaction and set the stage for improving the diagnosis and treatment of thrombotic thrombocytopenic purpura."}, {"pubmed": 12615692, "text": "This article reviews the role of this cleavage in regulating vWF-platelet interaction and proposes a scheme for understanding how a deficiency of ADAMTS13 results in the development of microthrombi in patients with thrombotic thrombocytopenic purpura."}, {"pubmed": 12753286, "text": "deficiency of ADAMTS13 is a molecular mechanism responsible for familial thrombotic thrombocytopenic purpura"}, {"pubmed": 12855569, "text": "high titers of IgM and IgG antibodies that bound to ADAMTS-13, but did not neutralize protease activity, in a patient with thrombotic thrombocytopenic purpura probably influenced the half-life of ADAMTS-13 or its binding to the endothelial cell surface."}, {"pubmed": 12869506, "text": "truncation of the cysteine-rich/spacer domains caused a remarkable reduction in VWF-CP activity"}, {"pubmed": 12871390, "text": "REVIEW: mechanisms by which defects in ADAMTS13 cause TTP"}, {"pubmed": 12871391, "text": "REVIEW: defects in ADAMTS13 cause TTP and HUS"}, {"pubmed": 12923577, "text": "Acquired deficiency of this enzyme causes Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction"}, {"pubmed": 12975358, "text": "The ADAMTS13 propeptide is not required for folding or secretion, and does not perform the common function of maintaining enzyme latency."}, {"pubmed": 14512308, "text": "VWF73 is a specific substrate for ADAMTS-13"}, {"pubmed": 14512317, "text": "Severe deficiency of the von Willebrand Factor (VWF)-cleaving proteinase, ADAMTS13, is associated with the development of thrombotic thrombocytopenic purpura"}, {"pubmed": 14525793, "text": "an amino acid polymorphism in VWF may influence susceptibility to ADAMTS13 proteolysis"}, {"pubmed": 14563640, "text": "Molecular models of the metalloprotease, fifth domain of thrombospondin 1 (Tsp1-5), and Tsp1-8 domains of ADAMTS13 suggest that the missense mutations could cause structural defects in the mutants."}, {"pubmed": 14644076, "text": "No significant difference in ADAMTS-13 activity between the age- and sex-matched patients with benign and malignant brain tumors nor between the age matched patients with prostatic cancer."}, {"pubmed": 14727254, "text": "REVIEW: role in thrombotic thrombocytopenic purpura"}, {"pubmed": 14727255, "text": "REVIEW: processing of von Willebrand factor by ADAMTS-13 on endothelial cells"}, {"pubmed": 14727256, "text": "REVIEW: recent advances in cell culture expression and functional characterization of human rADAMTS-13"}, {"pubmed": 14727257, "text": "REVIEW: mutations in hereditary thrombotic thrombocytopenic purpura"}, {"pubmed": 14727259, "text": "the substitution of ADAMTS-13 by means of recombinant drug instead of plasma"}, {"pubmed": 14727263, "text": "REVIEW: ADAMTS-13 deficiency in childhood"}, {"pubmed": 14962303, "text": "thrombotic microangiopathy with severe ADAMTS13 deficiency is a distinct pathologic process."}, {"pubmed": 14976043, "text": "ADAMTS13 auto-antibodies from 25 patients with severe ADAMTS13 deficiency (acquired thrombotic thrombocytopenia purpura) was evaluated in vitro"}, {"pubmed": 15009458, "text": "Role of ADAMTS13 mutations in the pathogenesis of congenital thrombotic thrombocytopenic purpura."}, {"pubmed": 15009467, "text": "The metalloprotease ADAMTS-13 cleaves von Willebrand factor (VWF) at the Y842/M843 peptide bond located in the A2 domain."}, {"pubmed": 15126318, "text": "ADAMTS13 may have a role in congenital thrombotic thrombocytopenic purpura"}, {"pubmed": 15175818, "text": "in a Chinese population, the heterozygous 1423T polymorphism was not associated with ischemic stroke nor myocardial infarction"}, {"pubmed": 15182579, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15249683, "text": "Results suggest that von Willebrand factor domain A1 inhibits the cleavage of domain A2 by ADAMTS13, and that inhibition can be relieved by interaction of domain A1 with platelet platelet glycoprotein Ibalpha or certain glycosaminoglycans."}, {"pubmed": 15388580, "text": "This study demonstrates the susceptibility of ADAMTS13 to proteolytic inactivation and suggests possible roles for thrombin and plasmin at sites of vascular injury."}, {"pubmed": 15583740, "text": "analysis of the changing levels of ADAMTS13 activity during pregnancy and puerperium"}, {"pubmed": 15692254, "text": "The acquired or sporadic form of TTP is caused by circulating autoantibodies inhibiting ADAMTS-13 activity"}, {"pubmed": 15710227, "text": "Inhibited in the blood of a paatient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura."}, {"pubmed": 15711742, "text": "the 130-amino-acid cysteine-rich spacer domain harbors a major binding site for anti-ADAMTS-13 antibodies found in blood of patients"}, {"pubmed": 15774619, "text": "mutant lacking the TSP-1 and CUB domains was hyperactive under flow, suggesting that the C-terminal region may negatively regulate ADAMTS-13 activity"}, {"pubmed": 15774620, "text": "More than 50 ADAMTS13 mutations resulting in familial TTP have been reported"}, {"pubmed": 15809291, "text": "the interaction between von Willebrand factor and ADAMTS-13 is modulated by chloride ions"}, {"pubmed": 15824096, "text": "analysis of ADAMTS13 binding to von Willebrand factor"}, {"pubmed": 15842379, "text": "the ADAMTS-13 Pro475Ser polymorphism is not found in caucasians [letter]"}, {"pubmed": 15855280, "text": "ADAMTS13 was detected immunohistochemically in perisinusoidal cells which also expressed alpha-smooth muscle actin, confirming that these cells were activated HSCs. These results suggest that HSCs may be major cells producing ADAMTS13 in human liver."}, {"pubmed": 15865866, "text": "Review.  ADAMTS13 deficiency is a risk factor for the development of thrombotic thrombocytopenic purpura and related syndromes."}, {"pubmed": 15886321, "text": "reduction in the number of terminal sugars on N-linked glycan increases susceptibility of globular VWF to ADAMTS13 proteolysis and is associated with reduced plasma VWF:Ag and VWF:CB levels."}, {"pubmed": 15890682, "text": "IgG antibodies directed against ADAMTS13 were found in 97% of untreated patients with acute acquired thrombotic microangiopathies who had plasma levels of ADAMTS13 activity below 10%. The corresponding prevalence of IgM antibodies was 11%."}, {"pubmed": 15975930, "text": "the proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for recognition and cleavage of von Willebrand factor between amino acid residues Asp(1595) and Arg(1668)."}, {"pubmed": 16102037, "text": "ultra-large von Willebrand factor is cleaved by ADAMTS-13 under flow conditions (review)"}, {"pubmed": 16113782, "text": "analysis of transcriptional regulation of ADAMTS13"}, {"pubmed": 16141351, "text": "CUB-1 domain may serve as the docking site for ADAMTS13 to bind unusually large forms of von Willebrand factor (ULVWF) under flow, a critical step to initiate ULVWF proteolysis"}, {"pubmed": 16160007, "text": "Analysis of the individual effect and combinations of any amino acid substitutions showed that several sequence variations can interact with each other, thereby altering the phenotype of ADAMTS13 deficiency"}, {"pubmed": 16189276, "text": "Severe secondary ADAMTS13 deficiency is associated with sepsis-induced disseminated intravascular coagulation and may contribute to the development of renal failure"}, {"pubmed": 16203734, "text": "truncation of the ADAMTS13 protein at its cysteine-rich region eliminates its recognition by the antibodies without abolishing its von Willebrand factor-cleaving activity"}, {"pubmed": 16221672, "text": "ADAMTS13 controls the multimeric size of circulating von Willebrand factor by reacting at several binding sites."}, {"pubmed": 16286459, "text": "substrate recognition of ADAMTS13 for VWF depends on structural features or exosites on multimeric VWF that are missing from FRETS-VWF73"}, {"pubmed": 16322474, "text": "results imply that increased VWF susceptibility for ADAMTS13 is a constitutive property of classical VWD type 2A in an investigation of the impact of mutations commonly found in patients with VWD type 2A on ADAMTS13-dependent proteolysis of VWF"}, {"pubmed": 16391894, "text": "Decreased activity of ADAMTS13 was associated with thrombotic thrombocytopenic purpura"}, {"pubmed": 16453338, "text": "A homogeneous distribution of ADAMTS13(WT) in the Cis-Golgi and endoplasmic reticulum (ER) compartments, a reduction of ADAMTS13(Val88Met) in both compartments, while ADAMTS13(Gly1239Val) failed to reach the Cis-Golgi compartment and remained in the ER."}, {"pubmed": 16597588, "text": "CUB domains have a critical role in a novel cargo-selective mechanism for apical sorting of a soluble ADAMTS protease (ADAMTS13) in polarized cells"}, {"pubmed": 16634765, "text": "ADAMTS-13 activity, von Willebrand factor level and platelet activation are modified by physical stress (letter)"}, {"pubmed": 16755777, "text": "Mutation analysis of the ADAMTS 13 gene one single base frameshift insertion, 4143insA in 8 of 9 unrelated patients."}, {"pubmed": 16794526, "text": "present the cases of two lung transplant recipients who experienced a thrombotic microangiopathy associated with an acquired severe (<5%) deficiency in ADAMTS 13 activity"}, {"pubmed": 16807643, "text": "4143insA has a common genetic background and is frequent among patients with hereditary ADAMTS13 deficiency in Northern and Central European countries"}, {"pubmed": 16894459, "text": "ADAMTS-13 has a role in regulating platelet adhesion"}, {"pubmed": 16899464, "text": "the A1 domain of VWF contains the binding site of chloride ions that control allosterically the proteolysis by ADAMTS-13 of the Tyr1605-Met1606 bond in the A2 domain"}, {"pubmed": 16953270, "text": "analysis of the spacer domain of ADAMTS13 involved in binding of antibodies in thrombotic thrombocytopenic purpura"}, {"pubmed": 16990571, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17003922, "text": "Defective secretion and impaired activity of the mutants concur to determine an almost complete deficiency of ADAMTS13 activity in patients with a homozygous or two heterozygous ADAMTS13 mutations."}, {"pubmed": 17030346, "text": "Quantitative Western blot analysis of plasma ADAMTS13 antigen was performed in patients with Upshaw-Schulman syndrome."}, {"pubmed": 17053057, "text": "Similar to von Willebrand factor, the estimated risk of myocardial infarction was increased for every quartile of ADAMTS13 when compared to the lowest quartile"}, {"pubmed": 17087728, "text": "The susceptibility of VWF mutants to proteolysis of ADAMTS-13 decreased in the following order: von Willebrand disease type 2A > type 2B > type 2M > rVWF-WT"}, {"pubmed": 17121983, "text": "Ionic interactions of the Pro-1645-Lys-1668 region of the von Willebrand factor A2 domain with exosite on ADAMTS-13 play a significant role in mediating substrate recognition."}, {"pubmed": 17229645, "text": "ADAMTS-13 deficiency may play a role in the development of sepsis-associated thrombocytopenia and organ failure"}, {"pubmed": 17294528, "text": "Renal thrombotic microangiopathy (TMA) may be responsible for acquired ADAMTS13 deficiency and thereby triggered the generalization of TMA lesions."}, {"pubmed": 17296575, "text": "the L1565 variant of von Willebrand factor has a role in susceptibility to proteolysis by ADAMTS13"}, {"pubmed": 17395589, "text": "overexpression of protein O-fucosyltransferase 2 did not affect the secretion of wild-type ADAMTS13, it did increase the secretion of the ADAMTS13 TSR1,2 double mutant but not that of ADAMTS13 TSR1-8 mutant"}, {"pubmed": 17725738, "text": "heterogeneity with regard to ADAMTS13 activity and the absence of inhibitors in the majority of patients indicate that other factors are important in the pathogenesis of HIV-related thrombotic thrombocytopenic purpura"}, {"pubmed": 17764538, "text": "VWF parameters are reciprocally correlated with ADAMTS-13 activity in severe sepsis and septic shock but have no prognostic value regarding outcome"}, {"pubmed": 17768109, "text": "ADAMTS13/factor XI complexes are insignificant in plasma"}, {"pubmed": 17849048, "text": "Four mutations in ADAMTS13 which led to a secretion defect, a loss of enzymatic activity and a decreased binding to the substrate, are responsible for the hereditary thrombotic thrombocytopenic purpura."}, {"pubmed": 17901248, "text": "ADAMTS13 preferentially acts on platelet-VWF complexes under fluid shear stress"}, {"pubmed": 17922807, "text": "Specific to the type 2B VWD group was an increase in the percentage of high molecular weight VWF multimers, a decrease in the mean platelet count, and an increase in the ADAMTS-13 level"}, {"pubmed": 17928530, "text": "provided visual evidence for a shear rate-dependent action of ADAMTS13 that limits thrombus growth directly at the site of the ongoing thrombus generation process"}, {"pubmed": 17988227, "text": "ADAMTS13 MUTATIONS IN THE FAMILY OF A Upshaw-Schulman syndrome PATIENTS"}, {"pubmed": 18031293, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18031293, "text": "The high prevalence of R1060W ADAMTS-13 in adult onset TTP, together with its absence in childhood congenital TTP cases reported elsewhere, suggests it may be a factor in the development of late-onset thrombotic thrombocytopenic purpura."}, {"pubmed": 18166799, "text": "systemic inflammation results in an ADAMTS13 deficiency which activates hemostasis"}, {"pubmed": 18175284, "text": "ADAMTS-13 levels in multisystem thrombotic microangiopathy and other pathologic conditions [review]"}, {"pubmed": 18194418, "text": "It appears unlikely that ADAMTS-13 appreciably affects VWF antigen levels. It correlated positively with serum cholesterol, triglycerides & BMI, & negatively with HDL-cholesterol. Only multivariate analysis showed association with myocardial infarction."}, {"pubmed": 18223285, "text": "Survivors of an acute episode of acquired thrombotic thrombocytopenic purpura with severely reduced levels of ADAMTS13 and/or with anti-ADAMTS13 antibodies during remission have"}, {"pubmed": 18240172, "text": "ADAMTS13 deficiency is associated with severe thrombocytopenia and microangiopathic hemolytic anemia in conjunction with severe bilateral otitis media"}, {"pubmed": 18263586, "text": "a new mechanism of anthrax coagulopathy affecting the levels and functional activities of both VWF and its natural regulator ADAMTS13. This mechanism may contribute to hemorrhage and thrombosis typical in anthrax."}, {"pubmed": 18327408, "text": "MgSO(4) significantly enhanced the cleavage of the newly released ultra-large von Willebrand factor strings by ADAMTS-13."}, {"pubmed": 18332284, "text": "ADAMTS13 is decreased in malignant hypertension and associated with the severity of thrombotic microangiopathy, likely because of the release of VWF after endothelium stimulation"}, {"pubmed": 18433458, "text": "certain inflammatory cytokines selectively inhibit ADAMTS13 synthesis without triggering release of its known substrate, vWF."}, {"pubmed": 18449422, "text": "There was no association between VWF clearance and ADAMTS-13-mediated proteolysis in type 1 von Willebrand disease."}, {"pubmed": 18492805, "text": "FVIII plays a role in regulating proteolytic processing of von Willebrand factor (VWF) by ADAMTS13 under shear stress, which depends on the high-affinity interaction between FVIII and its carrier protein, VWF."}, {"pubmed": 18492952, "text": "By kinetic analysis of recombinant ADAMTS13 constructs, we show that the first thrombospondin-1, Cys-rich, and spacer domains of ADAMTS13 interact with segments of VWF domain A2 between Gln(1624) and Arg(1668)."}, {"pubmed": 18502798, "text": "A molecular model of the FRETS-VWF73 showed that the substrate can fit into the active site only if ADAMTS13 assumes a C-like shape and, interacting with the acidic 1653-1668 region of VWF"}, {"pubmed": 18521503, "text": "An imbalance between the decreased ADAMTS13:AC and its increased substrate may reflect the predisposing state for platelet thrombi formation in patients with advanced liver cirrhosis."}, {"pubmed": 18581589, "text": "Data show that the Pro475Ser polymorphism seems to be popular in the Korean population, and attenuates ADAMTS-13 plasma activity."}, {"pubmed": 18581589, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18609162, "text": "The imbalance between decreased ADAMTS13 activity and increased unusually large von Willebrand factor could contribute to severe acute pancreatitis pathogenesis through enhanced thrombogenesis."}, {"pubmed": 18665921, "text": "P475S polymorphism of ADAMTS13 resulted in moderately lowered activity without urea, and the P475S mutant was more labile to urea than the wild-type"}, {"pubmed": 18725999, "text": "in type 2B vWD, prolonged lifetimes of vWF bonds with GPIbalpha on circulating platelets may allow ADAMTS-13 to deplete large vWF multimers, causing bleeding"}, {"pubmed": 18756543, "text": "The short-term prognostic usefulness of ADAMTS13 testing during acute thrombotic thrombocytopenic purpura warrants further investigation because of limited prospective studies."}, {"pubmed": 18801485, "text": "the disintegrin-like domain of ADAMTS-13 functions in attenuating thrombus growth on diseased arteries exposed to a high shear rate"}, {"pubmed": 18833927, "text": "It cleaves Tyr842-Met843 peptide bonding in A2 domain on von Willebrand factor and Its deficiency leads to thrombotic thrombocytopenic purpura."}, {"pubmed": 18835837, "text": "Work reports how two different ADAMTS13 gene defects acting at two different levels lead to a severe deficiency of ADAMTS13."}, {"pubmed": 18981290, "text": "After its secretion, ADAMTS13 does not require N-glycans for its von Willebrand factor cleaving activity"}, {"pubmed": 18983500, "text": "The rapid expulsion and unfolding of long VWF strings that remain anchored to endothelial cells after secretion from Weibel-Palade bodies can alter the structure or exposure of some VWF monomeric A2 domains to create an ADAMTS-13-cleavable form."}, {"pubmed": 18988930, "text": "decreased ADAMTS13 is associated with consumptive coagulopathy."}, {"pubmed": 18996572, "text": "Findings suggest that the imbalance between plasma VWF and ADAMTS13 levels caused by left atrial remodeling might be closely associated with intra-atrial thrombus formation in atrial fibrillation patients."}, {"pubmed": 19027144, "text": "The CUB-1 domain is critical for ADAMTS-13 secretion and stability upon secretion."}, {"pubmed": 19041237, "text": "ADAMTS13 is a specific von Willebrand factor -cleaving metalloprotease found in plasma. This protease limits admission and persistence of large VWF multimers in the circulation, where they form abnormally large thrombi in the microvasculature."}, {"pubmed": 19047683, "text": "major influence of Ca(2+) upon ADAMTS13 function is mediated through binding to a high-affinity site adjacent to its active site cleft."}, {"pubmed": 19054323, "text": "VH1-69 derived antibodies directed towards ADAMTS13 develop in the majority of patients with acquired TTP."}, {"pubmed": 19069166, "text": "Functional deficiency of ADAMTS13 caused by genetic mutation and inhibitory autoantibodies leads to the accumulation of VWF multimers in the plasma and results in thrombotic thrombocytopenic purpura (TTP)."}, {"pubmed": 19116307, "text": "In a family with a history of chronic recurrent TTP, genetic analysis revealed a homozygous deletion of nucleotides 2930-2935 in ADAMTS13, leading to the replacement of Cys977 by a Trp and the deletion of Ala978 and Arg979 in the TSP1-6 repeat domain"}, {"pubmed": 19162307, "text": "Correlation between plasma activity of ADAMTS13 and coagulopathy, and prognosis in disseminated intravascular coagulation is reported."}, {"pubmed": 19190804, "text": "Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies."}, {"pubmed": 19190805, "text": "Variations in the ratio between von Willebrand factor and its cleaving protease, ADAMTS13, during systemic inflammation and association with severity and prognosis of organ failure."}, {"pubmed": 19190814, "text": "Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia."}, {"pubmed": 19234142, "text": "Essential role of the disintegrin-like domain in ADAMTS13 function."}, {"pubmed": 19253359, "text": "Postmortem ADAMTS13 activity levels may not be valid in establishing a diagnosis of TTP, and high inhibitor levels in this setting may be related to elevated PFH."}, {"pubmed": 19260037, "text": "thrombocytopenia and schistocytosis can be seen in quinine-associated TTP/HUS, the pathophysiology seems to be distinct from that seen in most cases of idiopathic TTP (i.e., severely decreased ADAMTS13 with an inhibitor)."}, {"pubmed": 19270304, "text": "The effects of mutations in ADAMTS13 on the von Willebrand factor release and proteolysis in malaria patients is reported."}, {"pubmed": 19389207, "text": "ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13 is reported."}, {"pubmed": 19422343, "text": "Development of a hyperreactive primary hemostatic system, as evidenced by high levels of fully functional VWF and a temporary ADAMTS13 deficiency during liver transplantation."}, {"pubmed": 19422532, "text": "In brains from aged individuals and patients with vascular dementia, ADAM-TS13 was localized to neurons, but was most prominently localized to corpora amylacea."}, {"pubmed": 19427680, "text": "An association is reported bewteen ADAMTS13 polymorphisms and risk of cardiovascular events in chronic coronary disease."}, {"pubmed": 19427680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19439298, "text": "Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients."}, {"pubmed": 19492149, "text": "low activity in sickle cell disease patients inversely correlates with extracellular haemoglobin levels"}, {"pubmed": 19506365, "text": "Assessing ADAMTS13 antigen & activity shows whether or not it is fully active in various conditions: liver cirrhosis, inflammatory bowel disease, cardiac surgery, pregnancy, oral contraceptive use, in the neonatal state & in normal individuals. Review."}, {"pubmed": 19541819, "text": "Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site."}, {"pubmed": 19574655, "text": "preliminary Xray structure"}, {"pubmed": 19584892, "text": "microthrombosis has a role in the pathogenesis of delayed cerebral ischemia, as a result of decreased ADAMTS13 activity and endothelium dysfunction"}, {"pubmed": 19587373, "text": "This novel VWF C-terminal binding site may participate as the initial step of a multistep interaction ultimately leading to proteolysis of VWF by ADAMTS13."}, {"pubmed": 19644711, "text": "Human renal tubular epithelial cells synthesize biologically active ADAMTS13 which may, after release from tubuli, regulate hemostasis in the local microenvironment."}, {"pubmed": 19654870, "text": "We have used flow cytometry to estimate the binding of these antibodies to ADAMTS13 and demonstrate that antibodies raised against the TSP and disintegrin domains detect conformation changes in the ADAMTS13"}, {"pubmed": 19682236, "text": "The Cys-rich and spacer domains are required for recognition of the cell-bound ultralarge VWF, but that the TSP1 2-8 repeats and the CUB domains appear to be dispensable."}, {"pubmed": 19718479, "text": "von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity may have roles in chronic heart failure"}, {"pubmed": 19729451, "text": "ADAMTS13 bound to endothelial cells and enhanced cleavage of VWF."}, {"pubmed": 19765208, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19765208, "text": "genetic association study of six ADAMTS13 snps in ischemic stroke patients"}, {"pubmed": 19765212, "text": "ADAMTS-13 binds to circulating VWF and may therefore be incorporated into a platelet-rich thrombus, where it can immediately cleave VWF that is unfolded by fluid shear stress."}, {"pubmed": 19809308, "text": "possible link between ADAMTS13 and microangiopathy in diabetes mellitus patients"}, {"pubmed": 19812385, "text": "Reactive oxygen species released by activated neutrophils have a prothrombotic effect, mediated in part by inhibition of VWF cleavage by ADAMTS13."}, {"pubmed": 19822897, "text": "Constitutive ADAMTS-13 released from endothelial cells may contribute to the maintenance of cell surfaces free of hyperadhesive VWF multimeric strings."}, {"pubmed": 19847791, "text": "review of ADAMTS13 gene variants associated with inherited ADAMTS13 deficiency and congenital thrombotic thrombocytopenic purpura [review]"}, {"pubmed": 19880749, "text": "2 crystal structures of ADAMTS13-DTCS (residues 287-685), an exosite-containing human ADAMTS13 fragment, at 2.6-A and 2.8-A resolution, were determined."}, {"pubmed": 19897584, "text": "Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS-13."}, {"pubmed": 19944670, "text": "two epitope sites for VWF binding in the spacer domain of ADAMTS13 using the lambda-phage surface display system were explored."}, {"pubmed": 19996632, "text": "quantify ADAMTS13 production in proliferating and nonproliferating human umbilical vein endothelial cells"}, {"pubmed": 20032502, "text": "An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF."}, {"pubmed": 20054668, "text": "decreased ADAMTS13 activity may be involved in not only sinusoidal microcirculatory disturbances, but also subsequent progression of liver injuries, eventually leading to multiorgan failure"}, {"pubmed": 20058209, "text": "Deficiency of ADAMTS13, due to autoimmune inhibitors in patients with acquired thrombotic thrombocytopenic purpura and mutations of the ADAMTS13 gene in hereditary cases, leads to VWF-platelet aggregation and microvascular thrombosis"}, {"pubmed": 20062916, "text": "Results suggest that decreased ADAMTS13 activity in combination with increased VWF concentrations may contribute to the complications in severe malaria."}, {"pubmed": 20075158, "text": "Site-directed mutagenesis, kinetic analyses, and peptide inhibition assays have identified a role for amino acid residues Arg(659), Arg(660), and Tyr(661) of ADAMTS13 in proteolytic cleavage of various substrates."}, {"pubmed": 20141578, "text": "Letter: Report HLA-DRB1*11 as a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians."}, {"pubmed": 20201926, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20307901, "text": "reduced ADAMTS13 might be associated with diabetic nephropathy"}, {"pubmed": 20390223, "text": "genetic polymorphism is associated with meningococcal sepsis"}, {"pubmed": 20553378, "text": "ADAMTS13 inactivation by plasmin as a potential cause of thrombotic thrombocytopenic purpura"}, {"pubmed": 20605782, "text": "FVIII and platelets are cofactors that regulate proteolysis of multimeric VWF by ADAMTS13 under physiological conditions."}, {"pubmed": 20624874, "text": "Results describe the amino acid residues involved in ADAMTS13 cleavage and the carbohydrate moieties of this enzyme."}, {"pubmed": 20647566, "text": "Two subsites, D187-R193 and D252-P256, in the ADAMTS13 metalloprotease domain play an important role in cleavage efficiency and site specificity in the proteolysis of von Willebrand factor."}, {"pubmed": 20664912, "text": "Report a spliced ADAMTS13 transcript in hepatic stellate cells and a hepatoma cell line that retains the 25th intron, retaining VWF-cleaving capability."}, {"pubmed": 20682599, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20682599, "text": "change ADAMTS13 activity might modulate the risk of DVT by altering vWF and FVIII levels, the polymorphisms analyzed in this study did not correlate with DVT risk among patients investigated."}, {"pubmed": 20695979, "text": "ADAMTS13 CUB and T2-8 domains influence proteolysis of platelet-decorated VWF strings in vivo"}, {"pubmed": 20704649, "text": "von Willebrand factor clearance does not involve proteolysis by ADAMTS-13"}, {"pubmed": 20705333, "text": "ADAMTS13 interacted with the rVWF A1, A2, A3 domains and full-length VWF, while TSP1 also bound to three A domains, especially to A2 and A3 domains."}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20923926, "text": "Loss of ADAMTS13 is associated with benign nephrosclerosis."}, {"pubmed": 20946172, "text": "novel disulfide-bond-reducing activity of ADAMTS-13 may prevent covalent lateral association and increased platelet adherence of plasma-type VWF multimers induced by high fluid shear stress"}, {"pubmed": 20958794, "text": "E2 may play a role in the regulation of VWF and ADAMTS13 gene expression and in its production in human endothelial cells"}, {"pubmed": 21077328, "text": "Determined protein structure of ADAMTS13 from D domain to S domain. (review)"}, {"pubmed": 21103662, "text": "Evaluation of collagen binding and fluorescence resonance energy transfer based assays to measure plasma ADAMTS13."}, {"pubmed": 21136020, "text": "von Willebrand factor and ADAMTS13 have a role in clinical outcome after cardioversion for atrial fibrillation"}, {"pubmed": 21196718, "text": "ADAMTS-13 levels in Kuwait. ADAMTS-13 was found to be severely deficient in TTP patients; significantly lower levels of ADAMTS-13 were not specific for TTP and can be found in other thrombocytopenic disorders"}, {"pubmed": 21238935, "text": "The current knowledge of structure-function aspects of ADAMTS13 and its involvement in the pathogenesis of thrombotic microangiopathies, are discussed."}, {"pubmed": 21275971, "text": "ADAMTS13 activity and the risk of thrombotic thrombocytopenic purpura relapse in pregnancy"}, {"pubmed": 21350095, "text": "An evaluation for systemic lupus erythematosus/antiphospholipid syndrome is warranted in children and adolescents with reduced ADAMTS13 activity and thrombotic microangiopathy."}, {"pubmed": 21385852, "text": "Cleavage assays consistently demonstrated that Ca((2)+) binding stabilized the A2 domain and impeded its unfolding, and consequently protected it from cleavage by ADAMTS13"}, {"pubmed": 21479334, "text": "a region in the ADAMTS13 CUB-2 domain, with conserved polar residues, might be involved in protein-protein interactions within the nucleus"}, {"pubmed": 21488199, "text": "Mutations within the ADAMTS13 gene were investigated in children with hemolytic uremic syndrome."}, {"pubmed": 21512165, "text": "Preeclampsia is associated with decreased levels of ADAMTS13, independently of von Willebrand factor."}, {"pubmed": 21535387, "text": "a model is presented for the development of anti-ADAMTS13 antibodies in previously healthy individuals that incorporates the recent identification of HLA DRB1*11 as a risk factor for acquired thrombotic thrombocytopenic purpura.[review]"}, {"pubmed": 21573942, "text": "Sustained deficiency of ADAMTS13 appears characteristic of idiopathic noncirrhotic intrahepatic portal hypertension, irrespective of severity of liver disease."}, {"pubmed": 21605335, "text": "Oxidized von Willebrand factor multimers are cleaved by leukocyte serine proteases, under conditions where high concentrations of oxidant species would severely reduce the proteolytic efficiency of ADAMTS-13."}, {"pubmed": 21606162, "text": "evaluation of ADAMTS13 antigen levels during the course of therapy and follow-up may offer additional useful information for the management of patients with thrombotic thrombocytopenic purpura."}, {"pubmed": 21676167, "text": "Letter: Report SNPs/mutations of ADAMTS13 in the Japanese population and estimation of the number of patients with Upshaw-Schulman syndrome."}, {"pubmed": 21705658, "text": "The recognition of VWF Leu1603 by ADAMTS13, in conjunction with previously reported remote exosites C terminal of the cleavage site, suggests a mechanism whereby the VWF P1-P1' scissile bond is brought into position over the active site for cleavage."}, {"pubmed": 21712537, "text": "Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain."}, {"pubmed": 21715306, "text": "Protease activity of ADAMTS13 is controlled by conformational changes in its substrate, von Willebrand factor (VWF), which are induced when VWF is subject to elevated rheologic shear forces. (Review)"}, {"pubmed": 21720563, "text": "Glomerular endothelial cells express and secrete ADAMTS13."}, {"pubmed": 21732076, "text": "Human neuroblastoma, astroglioma, foetal microglia & adult human brain endothelial cell lines expressed ADAMTS-13 mRNA constitutively. (IL)-1beta down-regulated ADAMTS-13 mRNA expression in astroglioma cells and microglial cells."}, {"pubmed": 21779388, "text": "Data show that an anti-VWF mAb against the VWF-A2 domain (A1555-G1595) reduces the proteolytic cleavage of VWF by ADAMTS13 under shear stress, suggesting the role of this region in interaction with ADAMTS13."}, {"pubmed": 21781265, "text": "Analysing the natural history of these USS patients based on ADAMTS13 gene mutations may help characterise their clinical phenotypes"}, {"pubmed": 21799176, "text": "Results suggest that the amino terminus of ADAMTS13, specifically the variable region of the spacer domain, is crucial for modulation of arterial thromboses under (patho)physiological conditions."}, {"pubmed": 21843064, "text": "This article considers the effect of polymorphisms on the expression and function of ADAMTS13 and speculates on their relevance in future therapies based on pharmacogenomics--{REVIEW}"}, {"pubmed": 21896483, "text": "Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis."}, {"pubmed": 21901237, "text": "Suggest that the novel cell-based assay may be applicable for rapid identification and mapping of anti-ADAMTS13 autoantibodies in patients with acquired thrombotic thrombocytopenic purpura."}, {"pubmed": 22070827, "text": "Findings suggest that ADAMTS13/VWF profiles may have important roles in the pathogenesis of DIC."}, {"pubmed": 22075512, "text": "A novel homozygous missense ADAMTS13 mutation Y658C was found in a patient with recurrent thrombotic thrombocytopenic purpura."}, {"pubmed": 22110247, "text": "Data suggest that high VWF and low ADAMTS13 plasma levels both increase the risk of ischemic stroke and myocardial infarction, and the risks associated with high VWF or low ADAMTS13 levels are further increased by the use of oral contraceptives."}, {"pubmed": 22163125, "text": "ADAMTS13 levels do not appear to be related to no-reflow phenomenon after primary percutaneous coronary intervention."}, {"pubmed": 22168261, "text": "The genetic association observed in the present study implies that the regulation of platelet-decorated ultra-large von Willebrand factor strings by ADAMTS13 may play a role in the development of cerebral malaria."}, {"pubmed": 22192749, "text": "A better characterization of ADAMTS13 structure/function combined to clinical trials led in TTP patients is crucial to evaluate the relevance of either a -plasma-purified or a -recombinant ADAMTS13 as a therapeutic agent."}, {"pubmed": 22205175, "text": "ADAMTS-2, -3, and -13 expression, but not that of ADAMTS-14, are increased in plaques causing AMI compared those associated with stable angina."}, {"pubmed": 22289888, "text": "Gain-of-function ADAMTS13 variants were more resistant to inhibition by anti-ADAMTS13 autoantibodies from patients with acquired idiopathic thrombotic thrombocytopenic purpura because of reduced binding by anti-ADAMTS13 IgGs."}, {"pubmed": 22289891, "text": "Sugar moieties on ADAMTS13 interact with MR, thereby promoting its endocytosis by antigen presenting cells."}, {"pubmed": 22298244, "text": "The imbalance between ADAMTS13 and VWF levels does not explain the development of VAT in HD patients by itself, although it should contribute for the hypercoagulability state."}, {"pubmed": 22314603, "text": "Progress can be attributed to discovery of the von Willebrand factor cleaving protease ADAMTS-13 whose absence in TTP has given the disorder a distinct molecular identity."}, {"pubmed": 22324373, "text": "utility of incorporating ADAMTS13 measurements into an individualized treatment algorithm in acquired thrombotic thrombocytopenic purpura"}, {"pubmed": 22370688, "text": "The discovery of ADAMTS13 has provided a critical impetus for understanding the regulation of von Willebrand factor activity by shear stress [review]"}, {"pubmed": 22398507, "text": "Letter/Case Report: identify p.C1024R as a novel disease-causing mutation for Upshaw-Schulman syndrome, representing a unique late-onset phenotype in Japan with a moderate deficiency of ADAMTS13 activity."}, {"pubmed": 22431572, "text": "Type 2A VWD appears to result from a complex intersection of mechanisms that include: (1) intracellular retention or degradation of VWF, (2) defective multimerization, (3) loss of regulated storage, and (4) increased proteolysis by ADAMTS13."}, {"pubmed": 22466813, "text": "Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis."}, {"pubmed": 22529288, "text": "An ADAMTS13 activity above 0.5% was measured in 26 (90%) patients and lower levels of activity were associated with earlier age at first TTP episode requiring plasma infusion, more frequent recurrences, and prescription of fresh-frozen plasma prophylaxis."}, {"pubmed": 22529289, "text": "Prophylactic administration of 200 units/kg recombinant human ADAMTS13 protected ADAMTS13 knockout mice from developing thrombotic thrombocytopenic purpura."}, {"pubmed": 22627385, "text": "A new ADAMTS13 missense mutation (D1362V) in thrombotic thrombocytopenic purpura diagnosed during pregnancy [case report]"}, {"pubmed": 22627470, "text": "These findings suggest that a portion of the haematologic benefit of aortic valve replacement may be due to a postoperative decline in ADAMTS-13 rather than solely to relief of AS as previously thought."}, {"pubmed": 22672482, "text": "ADAMTS-13 activity and autoantibodies classes and subclasses are of predictive value for acute episode severity in patients with acquired thrombotic thrombocytopenic purpura."}, {"pubmed": 22685231, "text": "Lys-plasminogen, an amino-terminal truncated form of plasminogen, was identified as the binding protein to ADAMTS13."}, {"pubmed": 22707719, "text": "chimeric proteases and substrates to examine the role of C-terminal domains of ADAMTS13 and ADAMTS5 in the recognition of their physiological cleavage sites in von Willebrand factor (VWF) and aggrecan, respectively"}, {"pubmed": 22768050, "text": "The effects of six synonymous and six non-synonymous variations, previously found in the gene of ADAMTS13, the von Willebrand Factor (VWF) cleaving hemostatic protease, have been investigated."}, {"pubmed": 22781599, "text": "The A1500E mutation resulted in VWF more susceptible to ADAMTS13-dependent proteolysis."}, {"pubmed": 22783805, "text": "study confirms the heterogeneity of ADAMTS13 defects and an association between ADAMTS13 genotypes and thrombotic thrombocytopenic purpura phenotype"}, {"pubmed": 22854959, "text": "Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease."}, {"pubmed": 22915644, "text": "ADAMTS13 reduces myocardial ischemia/reperfusion injury in mice and rhADAMTS13 could be of therapeutic value to limit myocardial ischemia/reperfusion injury."}, {"pubmed": 22922961, "text": "Data indicate that exposure of von Willebrand factor sites for glycoprotein Ibalpha binding and ADAMTS13 cleavage are coupled."}, {"pubmed": 23020229, "text": "This study was conducted to determine the effects of smoking on vWF and ADAMTS-13 antigen and activity levels in Arab males."}, {"pubmed": 23041092, "text": "A high ratio of von Willebrand factor/ADAMTS13 independently predicts major adverse cardiovascular events in patients with atrial fibrillation."}, {"pubmed": 23058857, "text": "Described is a family case of chronic-relapsing thrombotic thrombocytopenic purpura, caused by two not previously reported heterozygous mutations in the ADAMTS13 gene."}, {"pubmed": 23073062, "text": "Case Report: thrombotic thrombocytopenic purpura in multiple myeloma patient due to anti-ADAMTS13 antibodies."}, {"pubmed": 23141846, "text": "Letter: report association between variation in ADAMTS13 and aneurysmal subarachnoid hemorrhage."}, {"pubmed": 23144461, "text": "Cyclophilin B activity regulated secretion and activity of ADAMTS13."}, {"pubmed": 23225307, "text": "Reduced ADAMTS13 activity is a risk factor for pediatric arterial ischemic stroke."}, {"pubmed": 23233642, "text": "ADAMTS13 has a role in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura [review]"}, {"pubmed": 23266519, "text": "VWF and ADAMTS13 might play an important role in the onset of thrombotic microangiopathy and poor outcome after living donor liver transplantation"}, {"pubmed": 23346910, "text": "Mutations were examined for impact on ADAMTS13 function based on crystallographic data. Data indicate that: the position of the mutation, evolutionary conservation and codon usage of the affected mutation position are associated with disease parameters."}, {"pubmed": 23411128, "text": "Data suggest that ADAMTS-13 activity and inhibitor level at baseline cannot differentiate TTP response to plasma exchange therapy."}, {"pubmed": 23415418, "text": "Review the recent findings on residual ADAMTS13 activity and their implications for research and clinical practice in the field."}, {"pubmed": 23433535, "text": "Reduction of plasma ADAMTS13 and elevation in VWF might have a role in the pathogenesis of preeclampsia."}, {"pubmed": 23443151, "text": "We describe the mechanisms involved in ADAMTS13 autoimmunity with a focus on the role of B- and T-cells in the pathogenesis of this disorder. [review]"}, {"pubmed": 23446343, "text": "The C2362F mutation in the B2 domain makes VWF resistant to proteolysis by ADAMTS13."}, {"pubmed": 23481506, "text": "The VWF-pp/ADAMTS13 ratio was associated with disease severity in patients with severe sepsis or septic shock and may help identify patients at risk for multiple organ dysfunction by detecting severe imbalance between ULVWF secretion and ADAMTS13 level."}, {"pubmed": 23494361, "text": "Plasma ADAMTS-13 activity determined at diagnosis of DIC may help predict the risk of hemorrhagic events during and/or following DIC treatment with hematologic disorders."}, {"pubmed": 23523588, "text": "ADAMTS13 may play a role in not only thrombotic thrombocytopenic purpura, but also inflammation, oxidative stress, and atherosclerosis."}, {"pubmed": 23524258, "text": "KSRP and TTP have an antagonistic role in miR-155 biogenesis."}, {"pubmed": 23554033, "text": "In patients with active systemic lupus erythematosus or considerable cumulative tissue damage, ADAMTS-13 levels may be decreased and anti-ADAMTS-13 autoantibodies may partially mediate this reduction"}, {"pubmed": 23621748, "text": "Provide structural evidence that the P475S polymorphism in ADAMTS-13 leads to increased local structural instability, resulting in lowered affinity for the substrate without changing the reaction rate."}, {"pubmed": 23636243, "text": "this study reports the novel demonstration that proteolytic cleavage of type 2N and HPP VWF variants by ADAMTS13 in the presence of FVIII was variably reduced as compared with that of WT."}, {"pubmed": 23648131, "text": "Report an excess of rare coding single nucleotide variants of the ADAMTS13 gene in patients with deep vein thrombosis."}, {"pubmed": 23677910, "text": "Novel frameshift mutations in ADAMTS13 in two families with hereditary thrombotic thrombocytopenic purpura."}, {"pubmed": 23682841, "text": "The identification of four unrelated homozygous patients with an identical defect suggests that inherited GPVI deficiency is more frequent than previously suspected, at least in Chile"}, {"pubmed": 23683325, "text": "The WXXW motif is important for the secretion of ADAMTS13 and it modulates the proteolytic cleavage of von Willebrand factor by ADAMTS13 under denaturing conditions."}, {"pubmed": 23715102, "text": "Prevalence of congenital ADAMTS13 deficiency in the Japanese population was estimated about one individual in 1.1 x 106 to be homozygote or compound heterozygote for ADAMTS13 deficiency. [review]"}, {"pubmed": 23729372, "text": "TTP associated with severe, acquired ADAMTS13 deficiency is uncommon in children. The demographic and clinical features of these children are similar to the features of adults with TTP."}, {"pubmed": 23733198, "text": "In patients with diabetes, ADAMTS13 618Ala variant associated with less proteolytic activity, higher risk of chronic complications, and better response to ACEi therapy"}, {"pubmed": 23847193, "text": "analysis of partial ADAMTS13 deficiency, a common finding in atypical hemolytic uremic syndrome patients"}, {"pubmed": 23878316, "text": "The results indicate that the microvascular process induced by ADAMTS13 deficiency triggers complement activation on platelets and the endothelium, which may contribute to formation of thrombotic microangiopathy."}, {"pubmed": 24073552, "text": "Studied ADAMTS13 measurements in the diagnosis of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome."}, {"pubmed": 24106205, "text": "platelet activation at sites of vascular injury results in the release of high local concentrations of HMWM platelet-VWF that is more resistant to ADAMTS13, thereby facilitating platelet-plug formation."}, {"pubmed": 24120584, "text": "Several members of a family were found to have mutations in the ADAMTS13 gene, causing thrombotic thrombocytopenic purpura in a compound heterozygote. The p.G385E missense mutation presented here is novel."}, {"pubmed": 24186313, "text": "A subset of sickle cell disease patients was identified with undetectable ADAMTS13 activity."}, {"pubmed": 24333090, "text": "Investigating the influence of age, gender and ABO blood group on ADAMTS-13 antigen and activity levels in healthy Arabs."}, {"pubmed": 24338607, "text": "This review discusses the available evidence for a role of ADAMTS13 in various disease states and the potential therapeutic benefit of restoration of ADAMTS13 levels."}, {"pubmed": 24351199, "text": "Studied whether lower VWF and higher ADAMTS13 are associated with a high postoperative drainage after CABG."}, {"pubmed": 24354764, "text": "ADAMTS13-specific circulating immune complexes have a mechanistic role in the pathophysiology of thrombotic thrombocytopenic purpura"}, {"pubmed": 24357063, "text": "Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner."}, {"pubmed": 24386898, "text": "ADAMTS13 antigen and activity were decreased in participants with AA genotype, compared to AG and GG. There was significantly reduced ADAMTS13 antigen in AG compared to GG, but not in ADAMTS13 activity."}, {"pubmed": 24401653, "text": "prevalence of R1060W missense mutation in exon 24 ADAMTS13 in a sample of adult Egyptian thrombotic thrombocytopenic purpura patients"}, {"pubmed": 24406064, "text": "OLGs provide rigidity to peptide backbones, and our findings suggest that OLG in the A1-A2 linker region regulates VWF conformational changes under shear"}, {"pubmed": 24433405, "text": "This study suggests that single-nucleotide variations of ADAMTS13 may be a major determinant of inter-individual variability in the expression and/or function of the von Willebrand factor-cleaving protease."}, {"pubmed": 24449821, "text": "We propose that plasminogen activation on endothelial cells acts as a natural backup for ADAMTS13 to degrade obstructive platelet-VWF complexes."}, {"pubmed": 24550384, "text": "Comprehensive analysis of all detected enzymes showed a random interaction mechanism for ADAMTS13 with many available binding sites on the von Willebrand factor strings"}, {"pubmed": 24558203, "text": "VWF A2 domain stability provided by its 2 structural elements (vicinal disulphide bond and calcium-binding site) is a key protective determinant against Full Length-VWF cleavage by ADAMTS13."}, {"pubmed": 24679129, "text": "Suggest rADAMTS-13 as a treatment option for the prevention of microthrombosis and brain injury after aneurysmal subarachnoid hemorrhage."}, {"pubmed": 24681085, "text": "Flow dynamics can trigger reversible von Willebrand factor self-assembly and platelet-VWF-conglomerate accrual, which are regulated by ADAMTS13 to a time span needed by coagulation to stabilize it."}, {"pubmed": 24740645, "text": "Results support the use of FRETS-VWF73 over collagen binding assay for the assessment of ADAMTS13 severe deficiency."}, {"pubmed": 24942015, "text": "ADAMTS13 deficiency may be initially confused with immune thrombocytopenic purpura if hemolytic anemia is not severe and renal or neurological symptoms are not present."}, {"pubmed": 24950743, "text": "ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2."}, {"pubmed": 24977290, "text": "analysis of glycosylation sites on plasma derived ADAMTS13"}, {"pubmed": 25010251, "text": "Therefore, VWF multimer analysis is not a valid tool to diagnose TTP in the active phase of disease but may be helpful for the diagnosis of TTP patients in remission."}, {"pubmed": 25057114, "text": "3 family members had a heterozygous c.106_107delAG p.S36fs*102. It causes a frameshift mutation and a premature stop codon. The truncated 138-aa peptide likely is quickly degraded."}, {"pubmed": 25113276, "text": "Systemic inflammation complicating advanced cirrhosis is accompanied by reduced activity of ADAMTS13 promoting a prothrombotic function of von Willebrand factor, which can be employed to predict clinical outcome."}, {"pubmed": 25201004, "text": "assay may serve as a valuable research tool to investigate the biochemical characteristics of VWF and ADAMTS13 under shear flow."}, {"pubmed": 25242241, "text": "Mutations throughout the ADAMTS13 have been identified in congenital TTP patients. [review]"}, {"pubmed": 25422322, "text": "ADAMTS13 is inactivated by hypochlorous acid generated by neutrophils, which demonstrates that oxidation could be an important mechanism for ADAMTS13 inactivation during inflammation"}, {"pubmed": 25430937, "text": "Patients with beta-thalassemia major infected with HCV have low ADAMTS13 levels"}, {"pubmed": 25431165, "text": "Reduced levels of ADAMTS13 activity in the first trimester were associated with increased risk for thrombotic thrombocytopenic purpura."}, {"pubmed": 25442981, "text": "Data indicate that the p.D187H mutation impairs ADAMTS13 activity and secretion and may contribute to thrombotic thrombocytopenic purpura."}, {"pubmed": 25498844, "text": "ADAMTS13 activity is reduced and VWF:Ag expression is increased within 4 weeks of TIA or ischaemic stroke onset, and can promote enhanced platelet adhesion and aggregation in response to stimulation with collagen and ADP via VWF-mediated pathways"}, {"pubmed": 25512499, "text": "Electron microscopy demonstrated a \"closed\" conformation of WT ADAMTS13 and suggested a more \"open\" conformation for GoF ADAMTS13."}, {"pubmed": 25512528, "text": "Thus, ADAMTS13 is regulated by substrate-induced allosteric activation, which may optimize VWF cleavage under fluid shear stress in vivo"}, {"pubmed": 25523333, "text": "Acute kidney injury is present in more than half the patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity."}, {"pubmed": 25564400, "text": "the ADAMTS13 cysteine-rich domain has a role in VWF binding and proteolysis"}, {"pubmed": 25643015, "text": "ADAMTS-13 levels were associated with an increased risk of mortality in critically ill patients with SIRS especially those with septic syndromes."}, {"pubmed": 25782102, "text": "Unconjugated bilirubin directly inhibits ADAMTS13's ability to cleave both peptidyl and native VWF substrates."}, {"pubmed": 25824235, "text": "Reduced ADAMTS13 activity together with increased VWF levels were especially notable in patients with active disease and with aPLs."}, {"pubmed": 25846964, "text": "Increase of von Willebrand factor is associated with the risk of platelet thrombosis within the allograft during Lung Transplantation."}, {"pubmed": 25849793, "text": "ADAMTS13 substrate specificity"}, {"pubmed": 25903530, "text": "Monitoring of ADAMTS13 activity and inhibitor titre during pregnancy may help to guide management and to avoid disease recurrence. [review]"}, {"pubmed": 25904363, "text": "The p.R1819_C1948delinsS mutation has both haemorrhagic features (defective collagen binding, reduced VWF levels) and prothrombotic (ADAMTS13 resistance) features, and the latter probably mitigate the patient's bleeding symptoms."}, {"pubmed": 25916953, "text": "data suggest that increased levels of VWF and reduced levels of ADAMTS13 activity may contribute to the pathogenesis of cerebral infarction."}, {"pubmed": 25934476, "text": "we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci."}, {"pubmed": 26073931, "text": "Review/Meta-analysis: Low ADAMTS-13 levels are associated with an increased risk of myocardial infarction."}, {"pubmed": 26085195, "text": "Congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) caused by novel ADAMTS13 mutations."}, {"pubmed": 26121272, "text": "Stroke in human immunodeficiency virus infection is associated with a prothrombotic state, characterized by elevated von Willebrand factor and low ADAMTS13 levels"}, {"pubmed": 26139087, "text": "ADAMTS13 variants and ADAMTS13 activity do not contribute to an increased risk of preeclampsia in the general population"}, {"pubmed": 26168189, "text": "Increased von Willebrand factor, ADAMTS13, and D-Dimer levels and decreased ADAMTS13 activity/ADAMTS13 levels ratio are associated with renal dysfunction in patients with type 1 diabetes"}, {"pubmed": 26170332, "text": "analysis of the substrate recognition landscape of the metalloprotease ADAMTS13"}, {"pubmed": 26267233, "text": "Adult-onset congenital thrombotic thrombocytopenic purpura caused by a novel compound heterozygous mutation of the ADAMTS13 gene."}, {"pubmed": 26272487, "text": "Case Report: D173G mutation in the catalytic domain of ADAMTS-13, never described before, causes a severe form of Upshaw-Schulman syndrome."}, {"pubmed": 26338302, "text": "Recombinant ADAMTS13 was shown to be effective in averting severe acquired thrombotic thrombocytopenic purpura-like symptoms in rats."}, {"pubmed": 26345337, "text": "Type 2B mutations localized in the A1 domain could enhance the sensitivity to ADAMTS13-mediated proteolysis. When GPIbalpha participated, there was a dramatically increased proteolytic cleavage of VWF by ADAMTS13 to rVWF-WT, excluding some type 2B mutants."}, {"pubmed": 26366828, "text": "ADAMTS13 and VWF are co-expressed in microvascular endothelial cells."}, {"pubmed": 26391536, "text": "ADAMTS-13 conformational activation leads to cryptic epitope/exosite exposure in proximal and distal domains, increasing activity. 3 linker regions in the distal domains make it flexible, enabling the interaction of the proximal and the T8-CUB2 domains."}, {"pubmed": 26425683, "text": "Disappearing acts of ADAMTS13."}, {"pubmed": 26454844, "text": "ADAMTS-13 is a clinical target to reduce vWF degradation, improve vWF function, and potentially reduce bleeding during LVAD support."}, {"pubmed": 26456149, "text": "Implementation of a rapid turnaround assay for ADAMTS13 resulted in a significant reduction in plasma utilization for patients with suspected TTP, without an increase in mortality"}, {"pubmed": 26559391, "text": "ADAMTS-13 mutations differentiate between acute thrombotic microangiopathies"}, {"pubmed": 26566785, "text": "We found a high prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway and an apparently different penetrance of ADAMTS-13 mutations."}, {"pubmed": 26589836, "text": "von Willebrand factor and ADAMTS-13 are associated with the occurrence of venous thromboembolism in patients with cancer."}, {"pubmed": 26595154, "text": "ADAMTS13 is the key protease that regulates the multimeric state of VWF. Without ADAMTS13, VWF multimers can grow to pathologically large sizes. This is a risk factor for the life-threatening condition thrombotic thrombocytopenic purpura (TTP)"}, {"pubmed": 26616301, "text": "An in vitro model for LVAD associated aVWD demonstrated that ADAMTS-13 and platelets contribute to the depletion of HMWM of VWF."}, {"pubmed": 26747250, "text": "These data provide evidence for the involvement of CUB2 domain of ADAMTS13 - reactive CD4(+)T cells in the etiology of acquired thrombotic thrombocytopenic purpura."}, {"pubmed": 26759371, "text": "investigated the roles of ADAMTS13 and VWF in thrombotic events of patients with Connective Tissue Diseases"}, {"pubmed": 26773038, "text": "Glycan stabilization of the VWF A2 domain acts together with the Ca(2+)binding site and vicinal cysteine disulfide bond to control unfolding and ADAMTS13 proteolysis."}, {"pubmed": 26775093, "text": "ADAMTS13 does not appear to be associated to disease severity or the hemodynamic derangement in patients with cirrhosis."}, {"pubmed": 26872106, "text": "Significantly lower ADAMTS-13 levels and significantly higher VWF antigen levels were concluded to be the result of a pathological process rather than an etiological factor for Venous thromboembolism."}, {"pubmed": 26897861, "text": "ADAMTS13 is a von Willebrand factor-cleaving protease and its deficiency causes thrombotic thrombocytopenic purpura."}, {"pubmed": 27034431, "text": "These observations support the hypothesis that a significantly reduced ADAMTS13/VWF ratio in the coronary artery flow plays a pathogenic role in acute coronary syndromes (ACS) and suggest that transition from laminar to turbulent flow at sites of coronary stenosis further enhances VWF activation and deposition."}, {"pubmed": 27166361, "text": "Low ADAMTS-13 levels correlated with high levels of NTproBNP but had no independent prognostic significance. In conclusion, high VWF:Ag levels, probably representing endothelial dysfunction, are associated with prognosis in patients with AL amyloidosis, independently of other features of the disease or cardiac biomarkers."}, {"pubmed": 27174213, "text": "No correlation was found between VWF/ADAMTS13 and infarct size in patients. Patients suffering from intramyocardial hemorrhage had significantly higher VWF activity and lower ADAMTS13 activity. Intracoronary administration of rADAMTS13 did not decrease infarct size or IMH in a porcine model of myocardial ischaemia-reperfusion, disputing the idea that the imbalance in ADAMTS13 and VWF as the cause of no reflow."}, {"pubmed": 27207796, "text": "these results demonstrate that HNPs1-3 may be potent inhibitors of ADAMTS13 activity, likely by binding to the central A2 domain of VWF and physically blocking ADAMTS13 binding."}, {"pubmed": 27208743, "text": "ADAMTS13 activity, d-Dimer and cystatin C are associated with retinopathy in type 1 diabetic patients and are promising biomarkers for the diagnosis and monitoring of diabetic retinopathy"}, {"pubmed": 27379499, "text": "Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients."}, {"pubmed": 27412500, "text": "Rare genetic variants in the ADAMTS13 on Willebrand factor-binding domain contribute to pediatric stroke."}, {"pubmed": 27416846, "text": "Three cases of systemic lupus erythematosus with ADAMTS13 inhibitor-negative thrombotic microangiopathy were successfully treated with combination of mycophenolate mofetil, plasma exchange and steroid. [case reports]"}, {"pubmed": 27514025, "text": "The 'closed' conformation of ADAMTS-13 restricts its specificity and protects against fibrinogenolysis"}, {"pubmed": 27536857, "text": "ADAMTS13 haplotype had an independent protective effect on CAD and genetic variation of vWF V1565L polymorphism modulates ADAMTS13 activity."}, {"pubmed": 27559008, "text": "Low ADAMTS-13 activity is associated with an increased risk of coronary heart disease in the elderly, independently of VWF and established cardiovascular risk factors"}, {"pubmed": 27574189, "text": "findings highlight the complexity of glycan modifications on ADAMTS13, which may have implications for its interaction with immune- or clearance receptors containing carbohydrate recognition domains."}, {"pubmed": 27665541, "text": "Two novel ADAMTS13 mutations (p.I143T and p.Y570C) identified in two adolescence onset congenital thrombotic thrombocytopenic purpura patients were studied. Proteasome degradation of these ADAMTS13 mutants contributed to their reduced secretion."}, {"pubmed": 27696191, "text": "review to introduce the state of progress with respect to some of the theorized roles of ADAMTS13[review]"}, {"pubmed": 27737864, "text": "ADAMTS13 activity and VWF:Ag levels are both associated with an increased risk of all-cause and cardiovascular mortality."}, {"pubmed": 27746209, "text": "ADAMTS13-a disintegrin-like metalloproteinase with thrombospondin motif type 1 member 13-regulates a key physiological process of coagulation in the circulation by cleaving VWF multimers into small, inactive fragments. Low levels of ADAMTS13 in the blood may play a role in cardiovascular and hematological disorders, and clarifying its role may help improve disease management."}, {"pubmed": 27766025, "text": "IL-8, TNF-alpha, tissue factor, IL-8+tissue factor and TNF-alpha+tissue factor decreased the levels of ADAMTS13 secreted by umbilical vein endothelial cells."}, {"pubmed": 27771173, "text": "Our results indicate that the secondary TMA syndrome and its poor outcome is characterized by relative ADAMTS13 deficiency, inflammation, and complement activation with consumption via the classical and alternative pathways."}, {"pubmed": 27787621, "text": "ADAMTS13 activity appears to be an independent risk factor for incident prediabetes and type 2 diabetes."}, {"pubmed": 27802307, "text": "Three Single Nucleotide Variants (p.Val154Ile, p.Asp187His and p.Arg421Cys) showed reduced ex vivo and in vitro ADAMTS13 levels. However, the low frequency of these variants makes it difficult to confirm their association with Deep Vein Thrombosis."}, {"pubmed": 28033504, "text": "ADAMTS-13 levels are decreased in plasma of AML patients and the level of ADAMTS-13 is related to inflammation and infection of AML patients. Besides, low ADAMTS-13 level is one potential risk factor for AML"}, {"pubmed": 28087247, "text": "The levels of ADAMTS13 among neonates were higher as compared with healthy adults, despite a significant elevation of VWF antigen (Ag) and Ristocetin cofactor (RiCof) noted in all neonates."}, {"pubmed": 28088271, "text": "The pregnancy loss rate does not appear to be affected by both ADAMTS-13 and ADAMTS-19."}, {"pubmed": 28102428, "text": "The relative deficiency of plasma ADAMTS13 activity in subarachnoid haemorrhage patients may associate with worse outcome."}, {"pubmed": 28209710, "text": "These findings support an ADAMTS13 activation model in which VWF D4-CK engages the TSP8-CUB2 domains, inducing the conformational change that disrupts the CUB1-spacer domain interaction and thereby activates ADAMTS13"}, {"pubmed": 28370891, "text": "the N-linked glycans of ADAMTS-13 play a crucial role in regulating ADAMTS-13 activity"}, {"pubmed": 28374895, "text": "Studied the significance of the von Willebrand factor (VWF)/ ADAMTS-13 ratio in advanced non-small-cell lung cancer (NSCLC). Findings suggest that the imbalance between VWF secretion and ADAMTS-13 may play a role in the hypercoagulability state in advanced NSCLC, and increase of the plasma VWF/ADAMTS-13 ratio may serve as an independent predictive factor for mortality in patients with advanced NSCLC."}, {"pubmed": 28447577, "text": "Low ADAMTS13 was associated with increased mortality in patients with severe sepsis and septic shock and was comparable to APACHE II scores for predicting mortality."}, {"pubmed": 28457019, "text": "vaso-occlusive crisis in sickle cell disease is associated with increased reactivity of VWF, without a pronounced ADAMTS-13 deficiency"}, {"pubmed": 28521259, "text": "Deficiency of the von Willebrand factor-cleaving protease ADAMTS13 is central to the pathophysiology of thrombotic thrombocytopenic purpura. Reviewed is the evidence emerged from epidemiological studies of an inverse relationship between the plasma levels of ADAMTS13 and the risk of acute coronary syndrome. [review]"}, {"pubmed": 28546076, "text": "Data indicate that in cultured endothelial cells, one role of endogenous ADAMTS-13 is regulation of angiogenesis, mediated through VEGF and AKT signaling pathway."}, {"pubmed": 28576877, "text": "both anti-ADAMTS13 IgG antibody and ADAMTS13 antigen levels correlate with outcome in thrombotic thrombocytopenic purpura with increased cardiac and neurological involvement and increased mortality."}, {"pubmed": 28591212, "text": "both in acute and chronic cerebrovascular disease patients, ADAMTS13 levels were significantly decreased, with the lowest ADAMTS13 levels found in acute stroke patients. This difference was even more distinct when the ratio of VWF:ADAMTS13 was considered. These results demonstrate the potentially important involvement of the VWF/ADAMTS13 axis in ischemic stroke."}, {"pubmed": 28751574, "text": "Placental trophoblasts and villous vessel endothelial cells produce a full-length and functional ADAMTS13 protease. Placental expression of ADAMTS13 exhibits a dynamic change during pregnancy, which seems to be inhibited in late pregnancy and in patients with severe preeclampsia."}, {"pubmed": 28765701, "text": "Complex VWF-ADAMTS13-mediated mechanisms disturb haemostasis in inflammatory bowel disease."}, {"pubmed": 28786769, "text": "Decreased ADAMTS-13 activity was found in patients with proliferative lupus nephritis, and plasma ADAMTS-13 activity was closely associated with renal injury indices."}, {"pubmed": 28815685, "text": "Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20."}, {"pubmed": 28980147, "text": "Missense variant in ADAMTS13 gene in a patient with NCIPH decreases secretion and activity of ADAMTS13 protein."}, {"pubmed": 29040872, "text": "These results suggest that highly elevated plasma VWF might accelerate platelet thrombus formation not only in the circulation but also on the surface of vascular endothelial cells in the setting of ADAMTS13 deficiency in Upshaw-Schulman syndrome."}, {"pubmed": 29077161, "text": "VWF, GMP-140, ADAMTS13 and the cerebral vasospasm, delayed cerebral ischemia, tumor diameter and prognosis of aneurysmal subarachnoid hemorrhage patients are closely related"}, {"pubmed": 29130325, "text": "The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis"}, {"pubmed": 29135310, "text": "ADAMTS 1, 4, 12, and 13 levels in the maternal and cord blood were lower in the preeclampsia group than in the control group. ADAMTS 1, 4, and 12 levels in placental tissues were higher in the preeclampsia group."}, {"pubmed": 29186156, "text": "As folding stability was progressively disrupted, proteolysis by ADAMTS13 increased. Due to the range of folding stabilities and wide distribution of VWF A2 domain mutations studied, we conclude that these mutations disrupt regulated folding of the VWF A2 domain"}, {"pubmed": 29222940, "text": "An open ADAMTS-13 conformation is also a hallmark of acute acquired thrombotic thrombocytopenic purpura, altering autoantibody binding."}, {"pubmed": 29228282, "text": "The endogenous plasmin activation alone is not sufficient to cause Thrombotic thrombocytopenic purpura (TTP), but plasmin activation with ADAMTS13 deficiency might increase the risk of TTP onset."}, {"pubmed": 29255356, "text": "Prothrombotic state and systemic inflammation status might contribute to explaining the high incidence of concealed chronic renal failure in COPD, and plasma ADAMTS-13 levels may serve as a strong predictor."}, {"pubmed": 29304523, "text": "ADAMTS13 open-closed conformations regulate the activity of this highly specific VWF cleaving protease in thrombotic thrombocytopenic purpura [review]"}, {"pubmed": 29304532, "text": "analysis of a follow-up study showing higher mortality or thrombotic complications and increased platelet count, increased VWF:Ag levels and decreased ADAMTS13 activity in colorectal cancer"}, {"pubmed": 29434246, "text": "Data confirm the critical role of exosite engagement for substrates to gain access to the active site of ADAMTS13, and define the substrate recognition motif for ADAMTS13."}, {"pubmed": 29534248, "text": "truncation of ADAMTS13 by plasmin abolishes intramolecular self-association, which improves interaction with unfolded von Willebrand Factor"}, {"pubmed": 29554699, "text": "analysis of ADAMTS13 variants in a patient cohort with Upshaw-Schulman Syndrome investigated in Germany"}, {"pubmed": 29615758, "text": "higher VWF and low ADAMTS13 activity are associated with increased risk of dementia"}, {"pubmed": 29618154, "text": "relative plasma deficiency of ADAMTS13 activity may be associated with more severe traumatic injury, significant endothelial glycocalyx damage, coagulation abnormalities and mortality after severe trauma in paediatric patients"}, {"pubmed": 29618156, "text": "Low ADAMTS-13 activity is a predictor of unfavourable outcome in patients with ischaemic stroke undergoing endovascular therapy"}, {"pubmed": 29636514, "text": "A novel insight into mechano-chemical regulation on interaction between ADAMTS13 and vWF A2 domain under forces is provided."}, {"pubmed": 29657197, "text": "ADAMTS-13 level was decreased in children with severe typical HUS and its deficiency correlated with disease severity."}, {"pubmed": 29771863, "text": "Upshaw-Schulman Syndrome With c.2728C>T Mutation in ADAMTS13 Gene."}, {"pubmed": 29887594, "text": "The aim of the study was to investigate the role of von Willebrand factor (vWF), the vWF-cleaving protease, ADAMTS13, the composition of thrombus, and patient outcome following mechanical cerebral artery thrombectomy in patients with acute ischemic stroke."}, {"pubmed": 29920743, "text": "Trp(390) residue within the WXXW motif is required for ADAMTS13 secretion and enzymatic activity"}, {"pubmed": 30006329, "text": "Through its action on VWF, ADAMTS13 can have prothrombotic and proinflammatory properties, not only when its activity is severely deficient, but also when it is only moderately low."}, {"pubmed": 30099840, "text": "Genetically predicted ADAMTS-13 activity, based on three genetic variants, is consistently inversely associated with ischemic heart disease but not with diabetes"}, {"pubmed": 30159948, "text": "protein C and ADAMTS-13 change were associated with outcome in an ongoing endothelial/hemostatic disorder was during sepsis"}, {"pubmed": 30312976, "text": "this study shows that in Upshaw-Schulman syndrome, age-onset defines two entities and ADAMTS13 sequence variations modify ADAMTS13 conformation"}, {"pubmed": 30322352, "text": "acute myeloid leukemia patients with low activity of ADAMTS-13 had worse prognosis after bone morrow transplantation."}, {"pubmed": 30429491, "text": "perioperative ADAMTS13-activity measurement may serve as a useful parameter to early detect high-risk patients developing postoperative liver dysfunction prior to liver resection in patients suffering from hepatic malignancies"}, {"pubmed": 30626079, "text": "ADAMTS13 rs2285489 genotyping in transplant recipients may be a useful tool for evaluating pretransplantation risks."}, {"pubmed": 30630232, "text": "Genetic analysis of 5 children with congentical thrombotic thrombocytopenia purpura showed complex heterozygous mutations at different loci of ADAMTS13 gene"}, {"pubmed": 30655285, "text": "The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension."}, {"pubmed": 30692120, "text": "Columba livia (pigeon) ADAMTS13 (pADAMTS13) resembles human delT3-6, retains normal activation by VWF D4, and has a SAXS envelope consistent with amputation of the hairpin containing the dispensable T domains of human ADAMTS13"}, {"pubmed": 30700419, "text": "ADAMTS13 and VWF have not evolved to be optimal enzyme-substrate pairs"}, {"pubmed": 30745808, "text": "antigen and activity both positively correlated with plasma viral load in HIV infection"}, {"pubmed": 30929293, "text": "To examine whether ABO(H) blood group antigens contributed to VWF cleavage, 82 plasma samples were exposed to high shear stress using a cone-plate shear stress inducer. The difference in the VWF-degradation products/VWF:Ag ratio before and after high shear stress in blood group O was significantly greater than those in groups A and AB."}, {"pubmed": 30936056, "text": "similar conditions facilitate VWF self-association and ADAMTS13-mediated proteolysis, with low calcium and A2 disease mutations enhancing both processes, and locking-A2 blocking them simultaneously"}, {"pubmed": 31006963, "text": "ADAMTS13 was stable at room temperature for up to 24 hours irrespective of the presence of citrate (0.38%). However, at 37 degrees C, citrate caused a time-dependent activity decrease. No ADAMTS13 activity decrease was seen in heparinized plasma, but the addition of citrate again caused ADAMTS13 instability at 37 degrees C."}, {"pubmed": 31067148, "text": "multiple sites on both molecules are involved in mechanically modulated VWF-ADAMTS13 interaction."}, {"pubmed": 31393047, "text": "Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor."}, {"pubmed": 31431443, "text": "Stroke is common after recovery from thrombotic thrombocytopenic purpura and is associated with reduced ADAMTS13 activity during remission."}, {"pubmed": 31439947, "text": "The crystal structure of the ADAMTS13 metalloprotease to spacer domains reveals that the metalloprotease domain exhibits a latent conformation in which the active-site cleft is occluded supporting the requirement for an allosteric change to enable accommodation of the substrate. Data demonstrate that von Willebrand factor (VWF) functions as both the activating cofactor and substrate for ADAMTS13."}, {"pubmed": 31482326, "text": "ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis."}, {"pubmed": 31691462, "text": "Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study."}, {"pubmed": 31758651, "text": "Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis."}, {"pubmed": 31990334, "text": "The VWF:Ag/ADAMTS13Ac ratio is a biomarker for the acute impact of an ischemic event and longer-term outcome."}, {"pubmed": 32065383, "text": "Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura."}, {"pubmed": 32073234, "text": "Novel mutations in ADAMTS13 CUB domains cause abnormal pre-mRNA splicing and defective secretion of ADAMTS13."}, {"pubmed": 32122366, "text": "Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock."}, {"pubmed": 32196618, "text": "Correlation analysis between ADAMTS-13 gene polymorphism and hypertension-induced atrial fibrillation."}, {"pubmed": 32222985, "text": "Tryptophan 387 and 390 residues in ADAMTS13 are crucial to the ability of vascular tube formation and cell migration of endothelial cells."}, {"pubmed": 32227485, "text": "Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis."}, {"pubmed": 32253422, "text": "HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR."}, {"pubmed": 32356859, "text": "Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura."}, {"pubmed": 32365113, "text": "analysis of seven ADAMTS13 missense variants under static conditions that may have a role in Upshaw-Schulman syndrome (USS), the congenital form of Thrombotic Thrombocytopenic Purpura (TTP)"}, {"pubmed": 32441353, "text": "Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity."}, {"pubmed": 32531546, "text": "In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease."}, {"pubmed": 32707276, "text": "A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19."}, {"pubmed": 32726827, "text": "Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura."}, {"pubmed": 32793509, "text": "Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment."}, {"pubmed": 32932544, "text": "von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli."}, {"pubmed": 33131251, "text": "Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura."}, {"pubmed": 33171004, "text": "Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura."}, {"pubmed": 33212380, "text": "ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis."}, {"pubmed": 33230904, "text": "The ADAMTS13-von Willebrand factor axis in COVID-19 patients."}, {"pubmed": 33290885, "text": "Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura."}, {"pubmed": 33343584, "text": "Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13."}, {"pubmed": 33362379, "text": "Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma."}, {"pubmed": 33369998, "text": "Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension."}, {"pubmed": 33404693, "text": "ADAMTS-13-VWF axis in sickle cell disease patients."}, {"pubmed": 33502080, "text": "Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients."}, {"pubmed": 33539188, "text": "Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin."}, {"pubmed": 33544829, "text": "N-glycan-mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP."}, {"pubmed": 33606732, "text": "Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients."}, {"pubmed": 33621545, "text": "Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases."}, {"pubmed": 33893632, "text": "Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis."}, {"pubmed": 33938341, "text": "The association of von willebrand factor and its cleaving protease (ADAMTS13) with health behaviours in young black and white adults: the African-PREDICT study."}, {"pubmed": 33974165, "text": "Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance."}, {"pubmed": 33989981, "text": "Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome."}, {"pubmed": 34105490, "text": "[Biological Function of CysR Domain of ADAMTS13]."}, {"pubmed": 34134958, "text": "[Correlation of serum ADAMTS13 and TSP1 levels with myocardial injury and prognosis in patients with acute coronary syndrome]."}, {"pubmed": 34310402, "text": "A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients."}, {"pubmed": 34352896, "text": "Inverse Regulation of Confluence-Dependent ADAMTS13 and von Willebrand Factor Expression in Human Endothelial Cells."}, {"pubmed": 34461090, "text": "Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity."}, {"pubmed": 34559219, "text": "Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP."}, {"pubmed": 34662354, "text": "Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis."}, {"pubmed": 34780600, "text": "Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models."}, {"pubmed": 34889809, "text": "Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma."}, {"pubmed": 34946607, "text": "Residues R1075, D1090, R1095, and C1130 Are Critical in ADAMTS13 TSP8-Spacer Interaction Predicted by Molecular Dynamics Simulation."}, {"pubmed": 34963692, "text": "The activity of the intrinsically water-soluble enzyme ADAMTS13 correlates with the membrane state when bound to a phospholipid bilayer."}, {"pubmed": 34977929, "text": "Diagnosis of Thrombotic Thrombocytopenic Purpura by ADAMTS13 Activity Quantification."}, {"pubmed": 35189860, "text": "Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis."}, {"pubmed": 35305536, "text": "Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Cause of Cryptogenic Stroke."}, {"pubmed": 35316498, "text": "COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm."}, {"pubmed": 35352474, "text": "Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia."}, {"pubmed": 35392493, "text": "Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea."}, {"pubmed": 35484652, "text": "ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology."}, {"pubmed": 35617796, "text": "Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura."}, {"pubmed": 35667091, "text": "Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance."}, {"pubmed": 35739601, "text": "Lombardy diagnostic and therapeutic network of thrombotic microangiopathy."}, {"pubmed": 35746657, "text": "Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19."}, {"pubmed": 35753044, "text": "Contribution of ADAMTS13-independent VWF regulation in sickle cell disease."}, {"pubmed": 35842925, "text": "ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura."}, {"pubmed": 35875933, "text": "Anti-inflammatory protective effect of ADAMTS-13 in murine arthritis models."}, {"pubmed": 36027630, "text": "Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis."}, {"pubmed": 36116391, "text": "Siglec-5 and Siglec-14 mediate the endocytosis of ADAMTS13."}, {"pubmed": 36281781, "text": "Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update."}, {"pubmed": 36306339, "text": "ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura."}, {"pubmed": 36368692, "text": "From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease."}, {"pubmed": 36474435, "text": "Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events."}, {"pubmed": 36537217, "text": "An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura."}, {"pubmed": 36546627, "text": "Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura."}, {"pubmed": 36696198, "text": "In vitro characterization of a novel Arg102 mutation in the ADAMTS13 metalloprotease domain."}, {"pubmed": 36736832, "text": "Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism."}, {"pubmed": 36765498, "text": "[Application Value of Plasma vWF and ADAMTS-13 in Evaluating Postoprative Vascular Endothelial Injury and Prognosis in Children with VSD]."}, {"pubmed": 37438087, "text": "Evaluating von Willebrand factor and ADAMTS13 levels in thalassemia major patients and assessing a possible association with Thrombospondin-1."}, {"pubmed": 37815743, "text": "Identification of 8 Rare Deleterious Variants in ADAMTS13 by Next-generation Sequencing in a Chinese Population with Thrombotic Thrombocytopenic Purpura."}, {"pubmed": 37889602, "text": "Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension."}, {"pubmed": 38002352, "text": "A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS."}, {"pubmed": 38123915, "text": "Ischemic Stroke Thrombus Perviousness Is Associated with Distinguishable Proteomic Features and Susceptibility to ADAMTS13-Augmented Thrombolysis."}, {"pubmed": 38149559, "text": "ADAMTS13 inhibits H2O2-induced human venous endothelial cell injury to attenuate deep-vein thrombosis by blocking the p38/ERK signaling pathway."}, {"pubmed": 38160729, "text": "ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura."}, {"pubmed": 38177376, "text": "ADAMTS13 regulates angiogenic markers via Ephrin/Eph signaling in human mesenchymal stem cells under serum-deprivation stress."}, {"pubmed": 38608066, "text": "Evaluating the potential mediating role of ADAMTS13 activity in the relationship between obesity and the severity of COVID-19: A retrospective cohort study."}, {"pubmed": 38723202, "text": "Improving our understanding on the clinical role of plasmin-mediated von Willebrand factor degradation."}], "genomic_pos": [{"chr": "9", "end": 133459402, "ensemblgene": "ENSG00000160323", "start": 133414358, "strand": 1}, {"chr": "HG2030_PATCH", "end": 285496, "ensemblgene": "ENSG00000281244", "start": 240452, "strand": 1}], "genomic_pos_hg19": [{"chr": "9", "end": 136324508, "start": 136279478, "strand": 1}, {"chr": "HG79_PATCH", "end": 136334921, "start": 136289893, "strand": 1}], "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006508", "qualifier": "involved_in", "term": "proteolysis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006508", "pubmed": 11535495, "qualifier": "involved_in", "term": "proteolysis"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007160", "pubmed": 11557746, "qualifier": "involved_in", "term": "cell-matrix adhesion"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007229", "pubmed": 11557746, "qualifier": "involved_in", "term": "integrin-mediated signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007596", "qualifier": "involved_in", "term": "blood coagulation"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0009100", "pubmed": 11557746, "qualifier": "involved_in", "term": "glycoprotein metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009636", "qualifier": "involved_in", "term": "response to toxic substance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0014075", "qualifier": "involved_in", "term": "response to amine"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0016485", "pubmed": 11557746, "qualifier": "involved_in", "term": "protein processing"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030163", "qualifier": "involved_in", "term": "protein catabolic process"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0030168", "pubmed": 11557746, "qualifier": "involved_in", "term": "platelet activation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030198", "qualifier": "involved_in", "term": "extracellular matrix organization"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035864", "qualifier": "involved_in", "term": "response to potassium ion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043171", "pubmed": 11535495, "qualifier": "involved_in", "term": "peptide catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071222", "qualifier": "involved_in", "term": "cellular response to lipopolysaccharide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071346", "qualifier": "involved_in", "term": "cellular response to type II interferon"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071353", "qualifier": "involved_in", "term": "cellular response to interleukin-4"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071356", "qualifier": "involved_in", "term": "cellular response to tumor necrosis factor"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005788", "qualifier": "located_in", "term": "endoplasmic reticulum lumen"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0009986", "pubmed": 11557746, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0031012", "qualifier": "is_active_in", "term": "extracellular matrix"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0031012", "pubmed": 11557746, "qualifier": "located_in", "term": "extracellular matrix"}], "MF": [{"category": "MF", "evidence": "EXP", "id": "GO:0004222", "pubmed": [12775718, 18983500, 31439947], "qualifier": "enables", "term": "metalloendopeptidase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004222", "qualifier": "enables", "term": "metalloendopeptidase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004222", "qualifier": "enables", "term": "metalloendopeptidase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005178", "pubmed": 11557746, "qualifier": "enables", "term": "integrin binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005509", "pubmed": 11557746, "qualifier": "enables", "term": "calcium ion binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [12775718, 16221672, 18492805, 25512528], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008237", "pubmed": 11557746, "qualifier": "enables", "term": "metallopeptidase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008270", "pubmed": 11557746, "qualifier": "enables", "term": "zinc ion binding"}]}, "homologene": {"genes": [[7955, 100320289], [8364, 100485801], [9031, 417152], [9598, 473153], [9606, 11093], [9615, 100630922], [9913, 532272], [10090, 279028], [10116, 102554393]], "id": 16372}, "interpro": [{"desc": "Spermadhesin, CUB domain superfamily", "id": "IPR035914", "short_desc": "Sperma_CUB_dom_sf"}, {"desc": "Thrombospondin type-1 (TSP1) repeat", "id": "IPR000884", "short_desc": "TSP1_rpt"}, {"desc": "Peptidase M12B, ADAM/reprolysin", "id": "IPR001590", "short_desc": "Peptidase_M12B"}, {"desc": "ADAM, cysteine-rich domain", "id": "IPR006586", "short_desc": "ADAM_Cys-rich"}, {"desc": "ADAMTS/ADAMTS-like, Spacer 1", "id": "IPR010294", "short_desc": "ADAMTS_spacer1"}, {"desc": "ADAMTS/ADAMTS-like", "id": "IPR013273", "short_desc": "ADAMTS/ADAMTS-like"}, {"desc": "Metallopeptidase, catalytic domain superfamily", "id": "IPR024079", "short_desc": "MetalloPept_cat_dom_sf"}, {"desc": "Thrombospondin type-1 (TSP1) repeat superfamily", "id": "IPR036383", "short_desc": "TSP1_rpt_sf"}, {"desc": "ADAMTS, cysteine-rich domain 2", "id": "IPR041645", "short_desc": "ADAMTS_CR_2"}, {"desc": "ADAMTS/ADAMTS-like, cysteine-rich domain 3", "id": "IPR045371", "short_desc": "ADAMTS_CR_3"}], "ipi": ["IPI00427822", "IPI00449028", "IPI00453457", "IPI00843978", "IPI01018932"], "map_location": "9q34.2", "name": "ADAM metallopeptidase with thrombospondin type 1 motif 13", "other_names": ["A disintegrin and metalloproteinase with thrombospondin motifs 13", "a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 13", "vWF-cleaving protease", "von Willebrand factor-cleaving protease"], "pantherdb": {"HGNC": "1366", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2685556", "ortholog_type": "LDO", "panther_family": "PTHR13723", "taxid": 10090, "uniprot_kb": "Q769J6"}, {"RGD": "1311594", "ortholog_type": "LDO", "panther_family": "PTHR13723", "taxid": 10116, "uniprot_kb": "D4A0T9"}, {"ZFIN": "ZDB-GENE-070814-7", "ortholog_type": "LDO", "panther_family": "PTHR13723", "taxid": 7955, "uniprot_kb": "A0A286Y999"}, {"WormBase": "WBGene00020567", "ortholog_type": "O", "panther_family": "PTHR13723", "taxid": 6239, "uniprot_kb": "A0A5A4YQ91"}, {"WormBase": "WBGene00000083", "ortholog_type": "O", "panther_family": "PTHR13723", "taxid": 6239, "uniprot_kb": "Q19204"}, {"FlyBase": "FBgn0032252", "ortholog_type": "O", "panther_family": "PTHR13723", "taxid": 7227, "uniprot_kb": "Q9VKV3"}, {"FlyBase": "FBgn0029791", "ortholog_type": "O", "panther_family": "PTHR13723", "taxid": 7227, "uniprot_kb": "Q9W493"}, {"dictyBase": "DDB_G0279795", "ortholog_type": "O", "panther_family": "PTHR13723", "taxid": 352472, "uniprot_kb": "O15916"}], "uniprot_kb": "Q76LX8"}, "pathway": {"reactome": [{"id": "R-HSA-109582", "name": "Hemostasis"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-3781865", "name": "Diseases of glycosylation"}, {"id": "R-HSA-3906995", "name": "Diseases associated with O-glycosylation of proteins"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-5083635", "name": "Defective B3GALTL causes PpS"}, {"id": "R-HSA-5173105", "name": "O-linked glycosylation"}, {"id": "R-HSA-5173214", "name": "O-glycosylation of TSR domain-containing proteins"}, {"id": "R-HSA-5668914", "name": "Diseases of metabolism"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-75892", "name": "Platelet Adhesion to exposed collagen"}, {"id": "R-HSA-9671793", "name": "Diseases of hemostasis"}, {"id": "R-HSA-9823587", "name": "Defects of platelet adhesion to exposed collagen"}, {"id": "R-HSA-9845619", "name": "Enhanced cleavage of VWF variant by ADAMTS13"}, {"id": "R-HSA-9845621", "name": "Defective VWF cleavage by ADAMTS13 variant"}], "wikipathways": {"id": "WP4561", "name": "Cell migration and invasion through p75NTR"}}, "pdb": ["3GHM", "3GHN", "3VN4", "6QIG", "7B01"], "pfam": ["PF00090", "PF01421", "PF05986", "PF17771", "PF19030", "PF19236", "PF13583"], "pharmgkb": "PA24539", "pharos": {"target_id": 10912, "tdl": "Tbio"}, "prosite": ["PS50092", "PS50215", "PS51257"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF177240", "relationship": "is"}, {"id": "GNF188146", "relationship": "is"}, {"id": "GNF199052", "relationship": "is"}, {"id": "GNF209958", "relationship": "is"}, {"id": "GNF223048", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF276684", "relationship": "is"}, {"id": "GNF276698", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF101298", "relationship": "is"}, {"id": "GNF140953", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000009.12", "NC_060933.1", "NG_011934.2", "NW_009646201.1"], "protein": ["NP_620594.1", "NP_620595.1", "NP_620596.2", "XP_011516478.1", "XP_011516480.1", "XP_011516481.1", "XP_016869721.1", "XP_016869722.1", "XP_016869723.1", "XP_016869724.1", "XP_047278655.1", "XP_047278656.1", "XP_054187537.1", "XP_054187538.1", "XP_054187539.1", "XP_054187540.1", "XP_054187541.1", "XP_054187542.1", "XP_054187543.1", "XP_054187544.1", "XP_054187545.1", "XP_054217833.1", "XP_054217834.1", "XP_054217835.1", "XP_054217836.1", "XP_054217837.1", "XP_054217838.1", "XP_054217839.1"], "rna": ["NM_139025.5", "NM_139026.6", "NM_139027.6", "NM_139028.2", "NR_024514.3", "XM_011518176.4", "XM_011518178.3", "XM_011518179.1", "XM_017014232.2", "XM_017014233.2", "XM_017014234.2", "XM_017014235.2", "XM_047422699.1", "XM_047422700.1", "XM_054331562.1", "XM_054331563.1", "XM_054331564.1", "XM_054331565.1", "XM_054331566.1", "XM_054331567.1", "XM_054331568.1", "XM_054331569.1", "XM_054331570.1", "XM_054361858.1", "XM_054361859.1", "XM_054361860.1", "XM_054361861.1", "XM_054361862.1", "XM_054361863.1", "XM_054361864.1"], "translation": [{"protein": "NP_620595.1", "rna": "NM_139026.6"}, {"protein": "XP_054217838.1", "rna": "XM_054361863.1"}, {"protein": "NP_620596.2", "rna": "NM_139027.6"}, {"protein": "XP_054187537.1", "rna": "XM_054331562.1"}, {"protein": "XP_054187542.1", "rna": "XM_054331567.1"}, {"protein": "XP_054187545.1", "rna": "XM_054331570.1"}, {"protein": "XP_054187543.1", "rna": "XM_054331568.1"}, {"protein": "XP_054187538.1", "rna": "XM_054331563.1"}, {"protein": "XP_011516481.1", "rna": "XM_011518179.1"}, {"protein": "XP_016869724.1", "rna": "XM_017014235.2"}, {"protein": "XP_047278656.1", "rna": "XM_047422700.1"}, {"protein": "XP_054187541.1", "rna": "XM_054331566.1"}, {"protein": "XP_016869723.1", "rna": "XM_017014234.2"}, {"protein": "XP_054217833.1", "rna": "XM_054361858.1"}, {"protein": "XP_016869721.1", "rna": "XM_017014232.2"}, {"protein": "XP_054217834.1", "rna": "XM_054361859.1"}, {"protein": "XP_054217837.1", "rna": "XM_054361862.1"}, {"protein": "XP_054187539.1", "rna": "XM_054331564.1"}, {"protein": "XP_054217836.1", "rna": "XM_054361861.1"}, {"protein": "XP_011516480.1", "rna": "XM_011518178.3"}, {"protein": "XP_054187540.1", "rna": "XM_054331565.1"}, {"protein": "XP_054217839.1", "rna": "XM_054361864.1"}, {"protein": "XP_011516478.1", "rna": "XM_011518176.4"}, {"protein": "NP_620594.1", "rna": "NM_139025.5"}, {"protein": "XP_016869722.1", "rna": "XM_017014233.2"}, {"protein": "XP_054187544.1", "rna": "XM_054331569.1"}, {"protein": "XP_047278655.1", "rna": "XM_047422699.1"}, {"protein": "XP_054217835.1", "rna": "XM_054361860.1"}]}, "reporter": {"GNF1H": "gnf1h08292_at", "HG-U133_Plus_2": ["220208_at", "223844_at"], "HTA-2_0": ["TC09000775.hg.1", "TC09002318.hg.1"], "HuEx-1_0": ["3192954", "4050866", "4051001", "4052015", "4052083"], "HuGene-1_1": "8159036", "HuGene-2_1": "17090786"}, "retired": [11032, 84212, 138059], "summary": "This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].", "symbol": "ADAMTS13", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413036"}, "unigene": "Hs.131433", "uniprot": {"Swiss-Prot": "Q76LX8", "TrEMBL": ["E7EV88", "A0A0B4J229", "A0A0C4DFV8", "F6V803"]}, "wikipedia": {"url_stub": "ADAMTS13"}}